| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Massagué J | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 597-641 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Annual Review of Cell Biology | Q27709680 |
| P1476 | title | The transforming growth factor-beta family | |
| P478 | volume | 6 |
| Q34758625 | 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells |
| Q33826120 | 1,25-dihydroxyvitamin d3 reduces extracellular matrix-associated protein expression in human uterine fibroid cells |
| Q73028701 | 1H, 13C, and 15N backbone assignments of the ligand binding domain of TGFbeta type II receptor |
| Q56505467 | 5 The in Vivo Roles of Müllerian-inhibiting Substance |
| Q36232792 | A 60-kD protein mediates the binding of transforming growth factor-beta to cell surface and extracellular matrix proteoglycans |
| Q50769739 | A 7.1 kbp beta-myosin heavy chain promoter, efficient for green fluorescent protein expression, probably induces lethality when overexpressing a mutated transforming growth factor-beta type II receptor in transgenic mice. |
| Q41380826 | A Duplicated, Truncated amh Gene Is Involved in Male Sex Determination in an Old World Silverside |
| Q41355369 | A Mouse Placental Immunoregulatory Factor Different from Transforming Growth Factor β |
| Q27309218 | A Novel, Noncanonical BMP Pathway Modulates Synapse Maturation at the Drosophila Neuromuscular Junction |
| Q40243393 | A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor |
| Q71848056 | A competitive quantitative polymerase chain reaction assay for bovine transforming growth factor-B1 mRNA |
| Q37388089 | A critical role for transforming growth factor-beta in donor transfusion-induced allograft tolerance |
| Q34616544 | A cuticle collagen encoded by the lon-3 gene may be a target of TGF-beta signaling in determining Caenorhabditis elegans body shape. |
| Q27653116 | A cytokine-neutralizing antibody as a structural mimetic of 2 receptor interactions |
| Q36841107 | A developmental gene (Tolloid/BMP-1) is regulated in Aplysia neurons by treatments that induce long-term sensitization |
| Q35661125 | A distinct regulatory region of the Bmp5 locus activates gene expression following adult bone fracture or soft tissue injury |
| Q40019241 | A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma |
| Q28118921 | A family of beta 7 integrins on human mucosal lymphocytes |
| Q30771011 | A fully human antibody neutralising biologically active human TGFbeta2 for use in therapy |
| Q34435654 | A glycosylation-deficient endothelial cell mutant with modified responses to transforming growth factor-beta and other growth inhibitory cytokines: evidence for multiple growth inhibitory signal transduction pathways |
| Q36976161 | A large bioactive BMP ligand with distinct signaling properties is produced by alternative proconvertase processing |
| Q42536276 | A malignant transformation of human cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin exhibits altered expressions of growth regulatory factors |
| Q35193411 | A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras |
| Q48042986 | A member of the TGF-beta receptor gene family in the parasitic nematode Brugia pahangi |
| Q67541752 | A model system for tumor angiogenesis: involvement of transforming growth factor-alpha in tube formation of human microvascular endothelial cells induced by esophageal cancer cells |
| Q41000778 | A new biological approach to vital pulp therapy |
| Q33570359 | A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype |
| Q44469073 | A new mutation (Leu569Arg) within Exon 13 of the TGFBI (BIGH3) gene causes lattice corneal dystrophy type I |
| Q47431967 | A novel 62-bp indel mutation in the promoter region of transforming growth factor-beta 2 (TGFB2) gene is associated with body weight in chickens |
| Q33739245 | A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion. |
| Q36654228 | A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells |
| Q38338332 | A proximal element within the human alpha 2(I) collagen (COL1A2) promoter, distinct from the tumor necrosis factor-alpha response element, mediates transcriptional repression by interferon-gamma |
| Q35671221 | A restricted spectrum of mutations in the SMAD4 tumor-suppressor gene underlies Myhre syndrome |
| Q41080642 | A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1 |
| Q41304148 | A synergistic relationship between TNF-alpha, IL-1 beta, and TGF-beta 1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line |
| Q44566980 | A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury |
| Q29622823 | A transcriptional partner for MAD proteins in TGF-beta signalling |
| Q39260980 | A transcriptionally active pRb-E2F1-P/CAF signaling pathway is central to TGFβ-mediated apoptosis |
| Q42943162 | A transforming growth factor beta-like immunosuppressive factor in immunoglobulin G-binding factor. |
| Q44527888 | ACE inhibition modulates transforming growth factor-beta receptors in the young rat. |
| Q74460983 | Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors |
| Q28284617 | Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction |
| Q73542905 | Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease |
| Q35796314 | Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1 |
| Q28138090 | Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology |
| Q40912782 | Activation of latent transforming growth factor beta |
| Q47767276 | Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats |
| Q28591649 | Activation of the murine type II transforming growth factor-beta receptor gene: up-regulation and function of the transcription factor Elf-3/Ert/Esx/Ese-1 |
| Q24315861 | Activation of transforming growth factor-beta is inhibited in transgenic apolipoprotein(a) mice |
| Q35266406 | Active cell death in hormone-dependent tissues |
| Q73371074 | Active collagen synthesis by pulmonary arteries in pulmonary hypertension complicated by congenital diaphragmatic hernia |
| Q77344264 | Active suppression in orally tolerized rats coincides with in situ transforming growth factor-beta (TGF-beta) expression in the draining lymph nodes |
| Q41977752 | Active transforming growth factor-beta in wound repair: determination using a new assay |
| Q40629888 | Activin A Induces Phosphorylation of Smad2 but Not Complex Formation of Smad2 with Smad4 in Human Colon Cancer Cell Line HT-29 |
| Q34396033 | Activin A promotes neuronal differentiation of cerebrocortical neural progenitor cells. |
| Q28610139 | Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis |
| Q38079493 | Activin, neutrophils, and inflammation: just coincidence? |
| Q28306205 | Adaptation of intestinal nutrient transport in health and disease. Part I |
| Q35363452 | Adaptive and innate transforming growth factor beta signaling impact herpes simplex virus 1 latency and reactivation |
| Q50504607 | Adverse cardiac remodelling in spontaneously hypertensive rats: acceleration by high aerobic exercise intensity. |
| Q73952564 | Alkaline phosphatase expression during monocyte differentiation. Overlapping markers as a link between monocytic cells, dendritic cells, osteoclasts and osteoblasts |
| Q24798834 | Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts |
| Q44382901 | Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension |
| Q48494187 | Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus |
| Q35851955 | Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice |
| Q71974492 | Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis |
| Q71612634 | Altered expression of transforming growth factor-beta S in chronic renal rejection |
| Q71654345 | Altered interaction of human granulation-tissue fibroblasts with fibronectin is regulated by α5β1 integrin |
| Q42639147 | Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1. |
| Q35916617 | Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode |
| Q36215506 | An ENU-induced p.C225S missense mutation in the mouse Tgfb1 gene does not cause Camurati-Engelmann disease-like skeletal phenotypes |
| Q40928797 | An active site of transforming growth factor-beta(1) for growth inhibition and stimulation |
| Q24318294 | An anti-proliferative gene BTG1 regulates angiogenesis in vitro |
| Q41152576 | An inositolphosphate glycan released by TGF-beta mimics the proliferative but not the transcriptional effects of the factor and requires functional receptors |
| Q40939136 | An interaction between human colon carcinoma cells and hepatocytes activates transforming growth factor-beta1 in vitro |
| Q28291529 | An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2 |
| Q77333240 | Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features |
| Q53416867 | Analyses of microsatellite instability and the transforming growth factor-beta receptor type II gene mutation in sporadic human gastrointestinal cancer. |
| Q43686111 | Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers. |
| Q51711517 | Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study. |
| Q90568619 | Analysis of novel domain-specific mutations in the zebrafish ndr2/cyclops gene generated using CRISPR-Cas9 RNPs |
| Q52212191 | Analysis of tooth development in mice bearing a TGF-beta 1 null mutation. |
| Q34136521 | Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105. |
| Q40833417 | Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies |
| Q85559287 | Angiogenesis-regulating microRNAs and Ischemic Stroke |
| Q34307651 | Antagonism of activin by inhibin and inhibin receptors: a functional role for betaglycan-glycan |
| Q79074390 | Antagonistic Effects of TNF-α on TGF-β Signaling Through Down-Regulation of TGF-β Receptor Type II in Human Dermal Fibroblasts |
| Q36342390 | Anterior segment dysgenesis after overexpression of transforming growth factor-beta-induced gene, beta igh3, in the mouse eye. |
| Q40909673 | Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor |
| Q73829474 | Antisense S-oligodeoxynucleotides down-regulate TGFbeta-production by Kupffer cells from CCl4-injured rat livers |
| Q39984618 | Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor |
| Q81310037 | Apoptosis, reactive oxygen species and follicular anti-Müllerian hormone in natural versus stimulated cycles |
| Q42519683 | Apoptotic versus proliferative activities in human benign prostatic hyperplasia |
| Q33837059 | Arginine kinase from Haemonchus contortus decreased the proliferation and increased the apoptosis of goat PBMCs in vitro |
| Q37709092 | Arrest of endotoxin-induced hypotension by transforming growth factor beta1. |
| Q33210191 | Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells |
| Q38408441 | Association of TGF-β1 +869C/T promoter polymorphism with susceptibility to autoimmune diseases: a meta-analysis |
| Q33869600 | Associations between genetic variants in the TGF-β signaling pathway and breast cancer risk among Hispanic and non-Hispanic white women |
| Q46004205 | Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice . |
| Q53960253 | Attenuating effects of heat shock against TGF-beta1-induced apoptosis in cultured rat hepatocytes. |
| Q36674035 | Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein |
| Q53636882 | Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity. |
| Q33937674 | Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225) |
| Q41590910 | Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells |
| Q47861156 | Autocrine transforming growth factor beta stimulation of extracellular matrix production by fibroblasts from fibrotic human gingiva |
| Q42469394 | Autocrine transforming growth factor-beta from chronic lymphocytic leukemia-B cells interferes with proliferative T cell signals. |
| Q48058415 | Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats |
| Q77338541 | Autoregulation of angiogenesis by cells of the vessel wall |
| Q48002286 | Axolotl (Ambystoma mexicanum) lymphocytes produce and are growth-inhibited by transforming growth factor-beta |
| Q41029867 | BMP signaling in Drosophila embryogenesis |
| Q33530933 | BMP-2 functions independently of SHH signaling and triggers cell condensation and apoptosis in regenerating axolotl limbs |
| Q57113363 | BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling |
| Q36118959 | BMP1 controls TGFbeta1 activation via cleavage of latent TGFbeta-binding protein |
| Q45734921 | BMP1-like proteinases are essential to the structure and wound healing of skin |
| Q37179550 | BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein |
| Q34244474 | Bcl-2 in cell-cycle regulation of hematopoietic cells by transforming growth factor-beta1. |
| Q34406454 | Betaglycan (TβRIII) is expressed in the thymus and regulates T cell development by protecting thymocytes from apoptosis |
| Q42982034 | Betaglycan has multiple binding sites for transforming growth factor-beta 1. |
| Q46222214 | Betaglycan knock-down causes embryonic angiogenesis defects in zebrafish |
| Q34572825 | Beyond Mitomycin: TGF-beta and wound healing |
| Q43522437 | Bidirectional effects of Kupffer cells on hepatocyte proliferation in vitro |
| Q33804111 | Bidirectional regulation of macrophage function by TGF-beta |
| Q41469668 | Biology of TGF-beta in knockout and transgenic mouse models |
| Q34283653 | Biology of kidney cells: ontogeny-recapitulating phylogeny |
| Q52586111 | Blackcurrant Anthocyanins Increase the Levels of Collagen, Elastin, and Hyaluronic Acid in Human Skin Fibroblasts and Ovariectomized Rats. |
| Q40858455 | Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas |
| Q37182998 | Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. |
| Q54399590 | Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. |
| Q37959987 | Bone grafts in craniofacial surgery |
| Q26744113 | Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies |
| Q39620793 | Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells. |
| Q35309820 | Bone morphogenetic protein-1 processes insulin-like growth factor-binding protein 3 |
| Q33993652 | Bone morphogenetic protein-2 and -6 heterodimer illustrates the nature of ligand-receptor assembly |
| Q40951487 | Bone morphogenetic protein-2 promotes survival and differentiation of striatal GABAergic neurons in the absence of glial cell proliferation |
| Q38066205 | Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy |
| Q36556405 | Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils |
| Q37418743 | CD105 positive neovessels are prevalent in early stage carotid lesions, and correlate with the grade in more advanced carotid and coronary plaques |
| Q86194775 | Calcium handling proteins: structure, function, and modulation by exercise |
| Q41087362 | Calpain and calpastatin in myoblast differentiation and fusion: effects of inhibitors |
| Q41332704 | Cancer gets Mad: DPC4 and other TGFbeta pathway genes in human cancer |
| Q46068592 | Ccn2/Ctgf overexpression induced by cigarette smoke during cutaneous wound healing is strain dependent. |
| Q40575372 | Cell biology of liver endothelial and Kupffer cells. |
| Q34006311 | Cell signaling by reactive nitrogen and oxygen species in atherosclerosis |
| Q72098046 | Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-β-stimulated mouse melanoma cell motility and invasive behavior on type I collagen |
| Q24610450 | Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis |
| Q33898303 | Cell-cell signaling between adult rat ventricular myocytes and cardiac microvascular endothelial cells in heterotypic primary culture |
| Q35750826 | Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation |
| Q40557640 | Cellular growth inhibition by TGF-beta1 involves IRS proteins |
| Q46955947 | Cellular heparan sulfate negatively modulates transforming growth factor-beta1 (TGF-beta1) responsiveness in epithelial cells |
| Q34177719 | Cellular interactions in vascular growth and differentiation |
| Q73043386 | Cellular localisation of transforming growth factor-beta 2 and -beta 3 (TGF-beta2, TGF-beta3) in damaged and regenerating skeletal muscles |
| Q73955405 | Ceramide mimics tumour necrosis factor-alpha in the induction of cell cycle arrest in endothelial cells. Induction of the tumour suppressor p53 with decrease in retinoblastoma/protein levels |
| Q44018997 | Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis |
| Q73016901 | Changes in levels of mRNAs of transforming growth factor (TGF)-beta1, -beta2, -beta3, TGF-beta type II receptor and sulfated glycoprotein-2 during apoptosis of mouse uterine epithelium |
| Q73247924 | Changes in local IFN-gamma and TGF-beta4 mRNA expression and intraepithelial lymphocytes following Eimeria acervulina infection |
| Q36429131 | Changes in serum transforming growth factor-β1 levels in chronic hepatitis C patients under antiviral therapy |
| Q44537772 | Changes in the expression of TGFbeta-isoforms in the anterior pituitary during withdrawal and resumption of feeding in hens |
| Q40375490 | Characteristics of a human prostate stromal cell line related to its use in a stromal-epithelial coculture model for the study of cancer chemoprevention. |
| Q73880893 | Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding |
| Q40879460 | Characterization of a newly established human pancreatic carcinoma cell line, UK Pan-1. |
| Q36543214 | Characterization of distinct functional domains of transforming growth factor beta |
| Q41059629 | Characterization of growth factor responsiveness and alterations in growth factor homeostasis involved in the tumorigenic conversion of mouse oval cells |
| Q54110034 | Characterization of protective immune responses in local lymphoid tissues after drug-attenuated infections with Ostertagia ostertagi in calves. |
| Q30793089 | Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). |
| Q37374932 | Characterization of transforming growth factor-beta (TGF-beta) receptors on BeWo choriocarcinoma cells including the identification of a novel 38-kDa TGF-beta binding glycoprotein |
| Q41277534 | Characterization of transforming growth factor‐β growth regulatory effects and receptors on bovine mammary cells |
| Q47919138 | Characterization of zebrafish smad1, smad2 and smad5: the amino-terminus of smad1 and smad5 is required for specific function in the embryo. |
| Q35069540 | Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients |
| Q36708416 | Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma |
| Q51649444 | Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells. |
| Q40059690 | Cholesterol modulates cellular TGF-beta responsiveness by altering TGF-beta binding to TGF-beta receptors |
| Q24294300 | Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis |
| Q48479939 | Choline availability modulates the expression of TGFbeta1 and cytoskeletal proteins in the hippocampus of developing rat brain |
| Q43574627 | Chromosome 3p tumor-suppressor gene alterations in cervical carcinomas |
| Q48844184 | Cigarette smoke-induced early growth response-1 regulates the expression of the cysteine-rich 61 in human skin dermal fibroblasts |
| Q42457908 | Ciliary body in experimental autoimmune uveitis: tissue repair and immunoreactivity of extracellular matrix substances |
| Q24311670 | Cloning and developmental expression of the chick type II and type III TGF beta receptors |
| Q48055252 | Cloning and sequencing of equine transforming growth factor-beta 1 (TGF beta-1) cDNA. |
| Q36738990 | Cloning of a growth arrest-specific and transforming growth factor beta-regulated gene, TI 1, from an epithelial cell line |
| Q36726542 | Cloning of an isoform of mouse TGF-beta type II receptor gene. |
| Q42522873 | Cloning of the 5'-flanking region of the murine bone morphogenetic protein-7 gene |
| Q47908589 | Cloning, expression profiling and promoter functional analysis of Bone morphogenetic protein 6 and 7 in tongue sole (Cynoglossus semilaevis). |
| Q52191473 | Co-expression of the proprotein-processing endoprotease furin and its substrate transforming growth factor beta1 and the differentiation of rat hepatocytes. |
| Q77344042 | Co-localization of immunoreactive transforming growth factor-beta 1 and decorin in bronchial biopsies from asthmatic and normal subjects |
| Q44755141 | Collagen I upregulates extracellular matrix gene expression and secretion of TGF-beta 1 by cultured human mesangial cells |
| Q78074223 | Collagen XVI is expressed by human dermal fibroblasts and keratinocytes and is associated with the microfibrillar apparatus in the upper papillary dermis |
| Q52767211 | Collagen metabolism is a novel target of the neuropeptide alpha-melanocyte-stimulating hormone. |
| Q77442014 | Collagen type XVI expression is modulated by basic fibroblast growth factor and transforming growth factor-beta |
| Q73428554 | Comparative analysis of transforming growth factor-beta isoforms 1-3 in human and rabbit dentine matrices |
| Q41123032 | Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines |
| Q40956363 | Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). |
| Q35027966 | Complexation and sequestration of BMP-2 from an ECM mimetic hyaluronan gel for improved bone formation |
| Q37309267 | Conditional expression of TGF-β1 in skeletal muscles causes endomysial fibrosis and myofibers atrophy |
| Q38327280 | Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts |
| Q34494584 | Contemporary immunosuppression in renal transplantation |
| Q38899586 | Context dependent non canonical WNT signaling mediates activation of fibroblasts by transforming growth factor-β. |
| Q36365305 | Control of CD4 effector fate: transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion |
| Q41271761 | Control of Integrin Expression by Extracellular Matrix |
| Q36080037 | Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1 |
| Q36684664 | Control of junB and extracellular matrix protein expression by transforming growth factor-beta 1 is independent of simian virus 40 T antigen-sensitive growth-sensitive growth-inhibitory events |
| Q24338254 | Control of pelage hair follicle development and cycling by complex interactions between follistatin and activin |
| Q71869147 | Cooperative Binding of Transforming Growth Factor (TGF)-β2 to the Types I and II TGF-β Receptors |
| Q52204300 | Coordinate patterns of expression of type I and III collagens during mouse development. |
| Q41268236 | Correlation of the size of type II transforming growth factor beta (TGF-beta) receptor with TGF-beta responses of isolated bovine articular chondrocytes |
| Q22008781 | Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12 |
| Q42819263 | Crystallization and preliminary X-ray analysis of recombinant human transforming growth factor beta 2 |
| Q77429585 | Cutaneous deposition diseases. Part II |
| Q24648922 | Cyclin A expression is under negative transcriptional control during the cell cycle |
| Q53426083 | Cyclosporine induces cancer progression by a cell-autonomous mechanism. |
| Q73292780 | Cytokine production by human soft tissue sarcomas: implications for immunosuppression within the tumour bed |
| Q41644094 | Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta |
| Q38986062 | Cytokines and Chemokines in Mycobacterium tuberculosis Infection |
| Q41165211 | Cytokines and production of surfactant components |
| Q41365089 | Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts |
| Q41197796 | Cytokines, growth factors, and other inflammatory mediators in glomerulonephritis |
| Q77787489 | DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression |
| Q33936594 | DPP and DSP are Necessary for Maintaining TGF-β1 Activity in Dentin |
| Q37244989 | Decoding the quantitative nature of TGF-beta/Smad signaling. |
| Q28581449 | Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart |
| Q41957297 | Decreased level of transforming growth factor-beta in blood lymphocytes of patients with aplastic anemia |
| Q44216035 | Defective post-thymic tolerance mechanisms during the chronic progressive stage of multiple sclerosis |
| Q38438924 | Demineralized bone matrix, as a graft enhancer of auto-local bone in posterior lumbar interbody fusion |
| Q41294837 | Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells |
| Q48275893 | Dependence of neurones on astrocytes in a coculture system renders neurones sensitive to transforming growth factor beta1-induced glutamate toxicity |
| Q72296822 | Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats |
| Q33833287 | Designing new treatment strategies in vital pulp therapy |
| Q35205890 | Determinants of specificity in TGF-beta signal transduction. |
| Q60700750 | Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-β1 in synovial fluid aspirates of patients with temporomandibular disorders |
| Q36611846 | Determining the effect of transforming growth factor-β1 on cdk4 and p27 in gastric cancer and cholangiocarcinoma |
| Q37201746 | Development of murine models to study Hepatitis C virus induced liver pathogenesis |
| Q33881274 | Development of specific connectivity between premotor neurons and motoneurons in the brain stem and spinal cord |
| Q28508686 | Developmental expression of latent transforming growth factor beta binding protein 2 and its requirement early in mouse development |
| Q52176766 | Developmental expression of the TGF beta s in the mouse cochlea. |
| Q52181429 | Developmental regulation of neuronal K+ channels by target-derived TGF beta in vivo and in vitro. |
| Q73280916 | Dietary docosahexaenoic acid ameliorates, but rapeseed oil and safflower oil accelerate renal injury in stroke-prone spontaneously hypertensive rats as compared with soybean oil, which is associated with expression for renal transforming growth fact |
| Q58135050 | Dietary protein induces endothelin-mediated kidney injury through enhanced intrinsic acid production |
| Q34416431 | Dietary transforming growth factor-beta 2 (TGF-β2) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. |
| Q36237924 | Different roles of TGF-β in the multi-lineage differentiation of stem cells. |
| Q71557045 | Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells |
| Q30830106 | Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone |
| Q67546049 | Differential effect of transforming growth factor beta on the synthesis of Th1- and Th2-like lymphokines by human T lymphocytes |
| Q71740166 | Differential effects of transforming growth factor-beta 1 on IgA vs. IgG2b production by lipopolysaccharide-stimulated lymph node B cells: a comparative study with spleen B cells |
| Q73304654 | Differential effects of transforming growth factors on localization of adhesion complex proteins following corneal epithelial cell wounding |
| Q43822302 | Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts |
| Q48059028 | Differential expression of bone morphogenetic proteins in the developing vestibular and auditory sensory organs. |
| Q73066781 | Differential expression of membrane-anchored proteoglycans in rabbit articular chondrocytes cultured in monolayers and in alginate beads. Effect of transforming growth factor-beta 1 |
| Q71532988 | Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy |
| Q47744537 | Differential gene expression of TGF-beta isoforms and TGF-beta receptors during the first trimester of pregnancy at the human maternal-fetal interface |
| Q43958470 | Differential modulation of transforming growth factor-betas and cyclooxygenases in the platelet lysates of male F344 rats by dietary lipids and piroxicam |
| Q40757687 | Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury |
| Q36289715 | Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. |
| Q42527076 | Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4. |
| Q36327496 | Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms |
| Q73689668 | Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells |
| Q42768300 | Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction |
| Q41674323 | Differential response of embryonic and fetal myoblasts to TGFβ: a possible regulatory mechanism of skeletal muscle histogenesis |
| Q41141172 | Differentiated properties and proliferation of arterial smooth muscle cells in culture. |
| Q51798377 | Diffusion chamber system for testing of collagen-based cell migration barriers for separation of ligament enthesis zones in tissue-engineered ACL constructs. |
| Q44067581 | Direct demonstration of transcriptional activation of collagen gene expression in systemic sclerosis fibroblasts: insensitivity to TGF beta 1 stimulation |
| Q24302117 | Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway |
| Q47341346 | Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts |
| Q54198896 | Distinct morphological and mito-inhibitory effects induced by TGF-beta 1, HGF and EGF on mouse, rat and human hepatocytes. |
| Q55058157 | Distribution of transforming growth factor-beta and its receptors in gastric carcinoma tissue. |
| Q41192340 | Divergent effect of TGFbeta1 on growth and proteolytic modulation of human prostatic-cancer cell lines |
| Q60961219 | Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells |
| Q46778172 | Does mutation of transforming growth factor-beta type II receptor gene play an important role in colorectal polyps? |
| Q40678531 | Dominant negative mutants of transforming growth factor-beta 1 inhibit the secretion of different transforming growth factor-beta isoforms |
| Q42730157 | Dose-related effects of the peroxisome proliferator methylclofenapate in rat liver |
| Q40706277 | Down-modulation of nuclear localisation and pro-fibrogenic effect of 4-hydroxy-2,3-nonenal by thiol- and carbonyl-reagents |
| Q36292375 | Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma |
| Q28218378 | Down-regulation of Id-1 expression is associated with TGF beta 1-induced growth arrest in prostate epithelial cells |
| Q50688552 | Down-regulation of TGFbeta1 and leptin ameliorates thioacetamide-induced liver injury in lipopolysaccharide-primed rats. |
| Q71959118 | Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages |
| Q36957620 | Downregulation of LIM kinase 1 suppresses ocular inflammation and fibrosis |
| Q79120868 | Downregulation of TGFβ isoforms and their receptors contributes to keratinocyte hyperproliferation in psoriasis vulgaris |
| Q33534117 | Downstream factors in transforming growth factor-beta family signaling |
| Q33412625 | Drosophila 60A gene, another transforming growth factor beta family member, is closely related to human bone morphogenetic proteins |
| Q36388492 | Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals |
| Q44434178 | Dynamics and Localization of Activin A Expression in Rat Gastric Ulcers |
| Q40551351 | Dysregulation of the TGF-beta postreceptor signaling pathway in cell lines derived from primary or metastatic ovarian cancer |
| Q24554533 | E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle arrest |
| Q36763397 | E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites |
| Q39264523 | Early gene regulation of osteogenesis in embryonic stem cells. |
| Q40641013 | Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function |
| Q39724790 | Early oral ovalbumin exposure during maternal milk feeding prevents spontaneous allergic sensitization in allergy-prone rat pups |
| Q33656926 | Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated |
| Q40775832 | Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition |
| Q41393986 | Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. |
| Q41629466 | Effect of TGF beta on liver genes expression. Antagonistic effect of TGF beta on IL-6-stimulated genes in Hep 3B cells |
| Q41341338 | Effect of TGF-beta on differentiated organoids of the colon carcinoma cell line LIM 1863. |
| Q44886467 | Effect of aldosterone on renal transforming growth factor-beta |
| Q48943010 | Effect of antisense suppression of transforming growth factor-beta3 gene on lactotropic cell proliferation |
| Q40730230 | Effect of enamel matrix derivative on the differentiation of C2C12 cells |
| Q35615736 | Effect of ethanol on pro-apoptotic mechanisms in polarized hepatic cells |
| Q33187788 | Effect of exogenous administration of transforming growth factor-beta and famotidine on the healing of duodenal ulcer under the impact of indomethacin |
| Q40958535 | Effect of intestinal epithelial cell cytokines on mucosal B-cell IgA secretion: enhancing effect of epithelial-derived IL-6 but not TGF-beta on IgA+ B cells |
| Q83948344 | Effect of pre-treatment with catecholamines on cold preservation and ischemia/reperfusion-injury in rats |
| Q46297250 | Effect of systemic calcium deficiency on the expression of transforming growth factor-beta in chick embryonic calvaria |
| Q42126393 | Effect of transforming growth factor beta and bone morphogenetic proteins on rat hepatic stellate cell proliferation and trans-differentiation |
| Q41883754 | Effect of transforming growth factor-beta 1 and basic fibroblast growth factor on the expression of cell surface proteoglycans in human lung fibroblasts. Enhanced glycanation and fibronectin-binding of CD44 proteoglycan, and down-regulation of glypi |
| Q52177924 | Effects of EGF and TGFbeta1 on c-myc gene expression and DNA synthesis in embryonic hamster palate mesenchymal cells. |
| Q35919719 | Effects of GnRH agonists on the expression of developmental follicular anti-mullerian hormone in varying follicular stages in cyclic mice in vivo |
| Q51141196 | Effects of TGF-β1 on plasminogen activation in human dental pulp cells: Role of ALK5/Smad2, TAK1 and MEK/ERK signalling. |
| Q70489737 | Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells |
| Q44101577 | Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients. |
| Q77566932 | Effects of intracranial injection of transforming growth factor-beta relevant to central fatigue on the waking electroencephalogram of rats: comparison with effects of exercise |
| Q51320068 | Effects of intrinsic stochasticity on delayed reaction-diffusion patterning systems. |
| Q77149859 | Effects of recombinant basic fibroblast growth factor, insulin-like growth factor-II and transforming growth factor-beta 1 on dog dental pulp cells in vivo |
| Q54723604 | Effects of transforming growth factor beta 1 on rainbow trout Oncorhynchus mykiss macrophage respiratory burst activity. |
| Q41504839 | Effects of transforming growth factor beta 1 on the adenylyl cyclase-cAMP pathway in prostate cancer |
| Q43956031 | Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene. |
| Q73231021 | Effects of transforming growth factors on dopaminergic neurons in culture |
| Q47598277 | Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling |
| Q41113888 | Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity. |
| Q35221977 | Elevated cysteine-rich 61 mediates aberrant collagen homeostasis in chronologically aged and photoaged human skin |
| Q42858939 | Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma |
| Q73184207 | Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome |
| Q42798611 | Elk-3 is a transcriptional repressor of nitric-oxide synthase 2. |
| Q36131471 | Embryo-maternal interactive factors regulating the implantation process: implications in assisted reproductive |
| Q36003155 | Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure |
| Q40570950 | Endogenous control of cell cycle progression by autocrine transforming growth factor beta in breast cancer cells |
| Q81454098 | Endogenous transforming growth factor beta 1 suppresses inflammation and promotes survival in adult CNS |
| Q24291272 | Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies |
| Q73031500 | Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2 |
| Q72102682 | Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF‐β1 |
| Q35043172 | Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy |
| Q36401309 | Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells |
| Q36623590 | Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer |
| Q33802356 | Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy |
| Q44858633 | Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. |
| Q38466614 | Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts |
| Q38628753 | Epithelial-mesenchymal transition in prostatic disease |
| Q43577795 | Estrogen and antiestrogen actions on transforming growth factorbeta (TGFbeta) in normal human breast epithelial (HBE) cells |
| Q41365042 | Etiologic links between chronic pancreatitis and pancreatic cancer |
| Q70250268 | Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1 |
| Q40845552 | Evidence for the involvement of dietary lipids on the modulation of transforming growth factor-beta1 in the platelets of male rats |
| Q36808476 | Evidence for the involvement of protein kinase activity in transforming growth factor-beta signal transduction |
| Q34401884 | Evolution of effectors and receptors of innate immunity |
| Q46052327 | Exogenous Transforming Growth Factor-Beta Amplifies Its Own Expression and Induces Scar Formation in a Model of Human Fetal Skin Repair |
| Q36366774 | Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance |
| Q74557848 | Experimental reconstruction of the mandible using polylactic acid tubes and basic fibroblast growth factor in alloplastic scaffolds |
| Q57044361 | Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy |
| Q74403170 | Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer |
| Q39992153 | Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines |
| Q54266480 | Expression and function of the Transforming Growth Factor-b system in the human and rat enteric nervous system. |
| Q41639273 | Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase |
| Q41699785 | Expression of Recombinant TGF-β2(442) Precursor and Detection in BSC-40 Cells |
| Q44364577 | Expression of TGF-beta receptors I and II in the human dental pulp by in situ hybridization |
| Q36897103 | Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells. |
| Q40859078 | Expression of cytokines and growth factors in human glomerulonephritides |
| Q77754324 | Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells |
| Q42982727 | Expression of extracellular matrix molecules in human mesangial cells in response to prolonged hyperglycaemia |
| Q43561396 | Expression of gene for EIIIA- and EIIIB- fibronectin, fetal types of fibronectin, during gastric ulcer healing in rats |
| Q54397136 | Expression of mRNA isoforms of latent transforming growth factor-β binding protein-1 in coronary atherosclerosis and human tissues. |
| Q48763347 | Expression of mRNAs coding for the transforming growth factor-beta receptors in brain regions of euthyroid and hypothyroid neonatal rats and in adult brain |
| Q40937438 | Expression of the wild-type insulin-like growth factor II receptor gene suppresses growth and causes death in colorectal carcinoma cells |
| Q35976726 | Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines |
| Q71615008 | Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells |
| Q80559563 | Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue |
| Q42515247 | Expression of transforming growth factor beta in the embryonic avian lens coincides with the presence of mitochondria. |
| Q73807243 | Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma |
| Q72822585 | Expression of transforming growth factor-beta 1 during diabetic renal hypertrophy |
| Q73495088 | Expression of transforming growth factor-beta in spontaneous chronic pancreatitis in the WBN/Kob rat |
| Q35832578 | Expression of transforming growth factor-beta isoforms in small round cell tumors of childhood. An immunohistochemical study |
| Q28569535 | Expression of transforming growth factor-beta receptor type I and type II in rat ventral prostate and Dunning R3327 PAP adenocarcinoma in response to castration and oestrogen treatment |
| Q24297609 | Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II |
| Q40729379 | Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells |
| Q28829653 | Extracellular interactions and ligand degradation shape the nodal morphogen gradient |
| Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
| Q24555664 | Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor |
| Q36550831 | FAR1 and the G1 phase specificity of cell cycle arrest by mating factor in Saccharomyces cerevisiae |
| Q42442971 | Factors modulating supernumerary hair cell production in the postnatal rat cochlea in vitro |
| Q40691694 | Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. |
| Q41080520 | Feedback inhibitors in normal and tumor tissues |
| Q40261533 | Feeder-free culture of human embryonic stem cells |
| Q34146060 | Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31. |
| Q35112972 | Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing |
| Q37377705 | Fibronectin binds and enhances the activity of bone morphogenetic protein 1. |
| Q27026644 | Fine-tuned shuttles for bone morphogenetic proteins |
| Q44997535 | First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction |
| Q39712885 | Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization |
| Q37411925 | Fractalkine and TGF-beta1 levels reflect the severity of chronic pancreatitis in humans |
| Q34691678 | From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells |
| Q33886281 | Functional genomics unique to week 20 post wounding in the deep cone/fat dome of the Duroc/Yorkshire porcine model of fibroproliferative scarring. |
| Q50430835 | Functional interaction between mesenchymal stem cells and spiral ligament fibrocytes. |
| Q40945911 | GDNF family members and their receptors: expression and functions in two oligodendroglial cell lines representing distinct stages of oligodendroglial development |
| Q36712439 | GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A. |
| Q40904463 | Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells |
| Q35119392 | Genealogy, expression, and cellular function of transforming growth factor-β |
| Q53406786 | Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma. |
| Q24533150 | Genetic characterization and cloning of mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster |
| Q42875977 | Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model |
| Q34361294 | Glial activation in the immature rat brain: implication of inflammatory transcription factors and cytokine expression |
| Q33884388 | Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells |
| Q34102569 | Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. |
| Q31154677 | Global gene expression in endometrium of high and low fertility heifers during the mid-luteal phase of the estrous cycle. |
| Q50525463 | Glucose-dependent regulation of DNA synthesis in bovine retinal endothelial cells. |
| Q50536117 | Glucose-mediated alteration of cellular function in human periodontal ligament cells. |
| Q28568144 | Golgi apparatus casein kinase phosphorylates bioactive Ser-6 of bone morphogenetic protein 15 and growth and differentiation factor 9 |
| Q72072696 | Growth Factor Effects on Cells of the Vascular Wall: A Survey |
| Q74453641 | Growth Factors |
| Q47568677 | Growth Factors and Chronic Wounds: The Need to Understand the Microenvironment |
| Q36457990 | Growth factor regulation of adrenal cortex growth and function |
| Q40596119 | Growth factor-induced cell migration: biology and methods of analysis |
| Q40840002 | Growth factor-induced retinal regeneration in vivo. |
| Q41689649 | Growth factors and hematopoietic stem cells |
| Q34973852 | Growth factors and steroid hormones: a complex interplay in the hypothalamic control of reproductive functions. |
| Q34356491 | Growth factors and wound healing: Part II. Role in normal and chronic wound healing |
| Q40914398 | Growth factors and wound healing: biochemical properties of growth factors and their receptors |
| Q41442987 | Growth factors in bladder cancer |
| Q34178829 | Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs |
| Q40876115 | Growth factors in glomerulonephritis |
| Q41545328 | Growth factors in hair organ development and the hair growth cycle |
| Q37253585 | Growth factors in melanoma |
| Q36351854 | Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA |
| Q46014736 | Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. |
| Q40933966 | Growth state-dependent regulation of plasminogen activator inhibitor type-1 gene expression during epithelial cell stimulation by serum and transforming growth factor-beta1. |
| Q41469446 | Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor |
| Q54122134 | Growth-inhibitory effects of transforming growth factor-beta 1 on myeloid leukemia cell lines. |
| Q73682044 | H(2)O(2) is an important mediator of physiological and pathological healing responses |
| Q45345231 | Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. |
| Q28365742 | Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis |
| Q73533414 | Heat shock response is associated with protection against acute interstitial pancreatitis in rats |
| Q34480115 | Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions |
| Q90318259 | Hepatic senescence, the good and the bad |
| Q28270220 | Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells |
| Q41245180 | Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo |
| Q41760360 | High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. |
| Q38989355 | High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy |
| Q50943279 | Honing Cell and Tissue Culture Conditions for Bone and Cartilage Tissue Engineering. |
| Q28284937 | Hucolin, a new corticosteroid-binding protein from human plasma with structural similarities to ficolins, transforming growth factor-beta 1-binding proteins |
| Q36429520 | Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: a role for transforming growth factor beta (TGF-beta) |
| Q52175916 | Human pulmonary acinar aplasia: reduction of transforming growth factor-beta ligands and receptors. |
| Q46608764 | Hyalocyte proliferation and ECM accumulation modulated by bFGF and TGF-beta1. |
| Q35547521 | Hyaluronan production in human rheumatoid fibroblastic synovial lining cells is increased by interleukin 1 beta but inhibited by transforming growth factor beta 1. |
| Q34457403 | Hypertension and the kidney |
| Q34028499 | Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence |
| Q74494488 | IFN-gamma inhibits the production of latent transforming growth factor-beta1 by mouse inflammatory macrophages |
| Q38519749 | IL-1beta induces and TGF-beta reduces vitamin D3-induced bone resorption in mouse calvarial bone cells. |
| Q77357541 | IL-4-mediated development of TGF-beta1-producing cells from naïve CD4(+) T cells through a STAT6-independent mechanism |
| Q24310196 | ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells |
| Q40351364 | Id proteins: novel targets of activin action, which regulate epidermal homeostasis |
| Q41651078 | Identification and Analysis of Transforming Growth Factor Beta Receptors on Primary Osteoblast-Enriched Cultures Derived from Adult Human Bone |
| Q24313124 | Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions |
| Q36594541 | Identification of a Drosophila activin receptor |
| Q34806677 | Identification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial Cells |
| Q41303147 | Identification of a chemotactic epitope in human transforming growth factor‐β1 spanning amino acid residues 368–374 |
| Q38304219 | Identification of a negative Cis-regulatory element and multiple DNA binding proteins that inhibit transcription of the transforming growth factor-beta type II receptor gene |
| Q48041235 | Identification of a novel member of the TGF-beta superfamily highly expressed in human placenta |
| Q37103128 | Identification of a structural domain that distinguishes the actions of the type 1 and 2 isoforms of transforming growth factor beta on endothelial cells |
| Q28155857 | Identification of glucocorticoid receptor domains involved in transrepression of transforming growth factor-beta action |
| Q24312381 | Identification of glucose-regulated genes in human mesangial cells by mRNA differential display |
| Q73917827 | Identification of new bone morphogenetic protein-related members in invertebrates |
| Q24309454 | Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein |
| Q48071675 | Identification of two Drosophila TGF-? family members in the grasshopper Schistocerca americana |
| Q50026767 | Identifying potential maternal genes of Bombyx mori using digital gene expression profiling. |
| Q42830035 | Immediate early gene responses of NIH 3T3 fibroblasts and NMuMG epithelial cells to TGF beta-1. |
| Q40924381 | Immediate postnatal rat heart development modified by abdominal aortic banding: analysis of gene expression |
| Q35833129 | Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma |
| Q53505180 | Immunohistochemical characteristics of intramural leiomyomata that enlarge during controlled ovarian hyperstimulation for in vitro fertilization. |
| Q73746260 | Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in normal and malignant human prostate |
| Q45194116 | Immunohistochemical localization of growth factors in fetal wound healing |
| Q78168531 | Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors |
| Q23923074 | Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases |
| Q48970283 | Immunohistochemical localization of transforming growth factor-beta 1 beta 2 during folliculogenesis in the quail ovary |
| Q78575296 | Immunolocalization of a new intestinal antiproliferative factor in human intestinal epithelial cells |
| Q77642818 | Immunolocalization of transforming growth factor-beta 3 in pregnant human myometrium |
| Q40656756 | Immunopathogenesis of systemic sclerosis: possible role of retroviruses |
| Q34073758 | Immunophilins: switched on protein binding domains? |
| Q33908046 | Immunosuppressive drugs: the first 50 years and a glance forward |
| Q67650527 | Immunosuppressive factors in porcine vitreous body |
| Q34538722 | Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function |
| Q92313984 | Impact of SNPs/Haplotypes of IL10 and IFNG on the Development of Diffuse Large B-Cell Lymphoma |
| Q24626938 | Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts |
| Q54321250 | Impaired cutaneous wound healing in transforming growth factor-β inducible early gene1 knockout mice. |
| Q28360412 | Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis |
| Q43576654 | Impairment of mammary lobular development induced by expression of TGFbeta1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice |
| Q40583089 | In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. |
| Q61736748 | In vitro cell response on CP-Ti surfaces functionalized with TGF-β1 inhibitory peptides |
| Q47985889 | In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators |
| Q73418940 | In vitro release kinetics of biologically active transforming growth factor-beta 1 from a novel porous glass carrier |
| Q40852992 | In vitro wound repair by human gastric fibroblasts: implications for ulcer healing |
| Q33641428 | In vivo delivery of Gremlin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by recovering bone morphogenetic protein-7. |
| Q24319995 | Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability |
| Q37061943 | Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor β1 |
| Q35833381 | Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. |
| Q34122017 | Increased expression of basement membrane collagen in human diabetic retinopathy |
| Q33526463 | Increased expression of collagens, transforming growth factor-beta1, and -beta3 in gluteal muscle contracture |
| Q38622506 | Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts |
| Q48824445 | Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? |
| Q73161999 | Increased expression of transforming growth factor-beta1 during gastric ulcer healing in rats |
| Q42469272 | Increased immunoreactivity of collagen types I, III and V, fibronectin and TGF-beta in retinal vessels of rats with experimental autoimmune uveoretinitis |
| Q34649842 | Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice |
| Q74341083 | Increased type II transforming growth factor-beta receptor expression in liver cells during cholesterol challenge |
| Q73065154 | Induction of alpha1-antitrypsin synthesis in human articular chondrocytes by interleukin-6-type cytokines: evidence for a local acute-phase response in the joint |
| Q24527335 | Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector |
| Q41640419 | Induction of epithelial branching tubulogenesis in vitro |
| Q41813743 | Induction of interleukin-6 in human retinal epithelial cells by an attenuated Herpes simplex virus vector requires viral replication and NFkappaB activation |
| Q72036047 | Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer |
| Q24633311 | Induction of primordial germ cells from murine epiblasts by synergistic action of BMP4 and BMP8B signaling pathways |
| Q36530983 | Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine |
| Q34109863 | Induction of vascular endothelial tubular morphogenesis by human glioma cells. A model system for tumor angiogenesis |
| Q41719281 | Inflammation and TGF beta 1: lessons from the TGF beta 1 null mouse |
| Q28534387 | Inflammation's Association with Metabolic Profiles before and after a Twelve-Week Clinical Trial in Drug-Naïve Patients with Bipolar II Disorder |
| Q35116249 | Inflammatory regulation of valvular remodeling: the good(?), the bad, and the ugly |
| Q53560257 | Influence of TGF-beta1 on the expression of BSP, DSP, TGF-beta1 receptor I and Smad proteins during reparative dentinogenesis. |
| Q35093612 | Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy |
| Q36345330 | Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic mice |
| Q45122645 | Inhibition of transforming growth factor beta decreases pancreatic fibrosis and protects the pancreas against chronic injury in mice |
| Q41685121 | Inhibition of transforming growth factor-beta type II receptor signaling accelerates tooth formation in mouse first branchial arch explants |
| Q67737256 | Inhibition of tumor implantation at sites of trauma by Arg-Gly-Asp containing proteins and peptides |
| Q40432874 | Inhibitory effect of agmatine on proliferation of tumor cells by modulation of polyamine metabolism. |
| Q42831022 | Initial characterization of mitogenic activity of ovine corpora lutea from early pregnancy |
| Q93126280 | Insights into the HIV Latency and the Role of Cytokines |
| Q40755306 | Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells |
| Q72210593 | Insulinlike growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells |
| Q41234001 | Integrated processes responsible for soft tissue healing |
| Q24620638 | Integrating with integrins |
| Q42075812 | Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail |
| Q36604045 | Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy |
| Q92784010 | Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment |
| Q34888903 | Interactions among regulators of RNA abundance characterized using RNA fingerprinting by arbitrarily primed PCR |
| Q24644444 | Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1 |
| Q41546005 | Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules |
| Q34719524 | Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata |
| Q77922113 | Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro |
| Q73880625 | Interleukin-10 and transforming growth factor-beta inhibit amniochorion tumor necrosis factor-alpha production by contrasting mechanisms of action: therapeutic implications in prematurity |
| Q48715449 | Interleukin-13 and transforming growth factor-beta1 inhibit spontaneous sleep in rabbits |
| Q42500213 | Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells |
| Q35824163 | Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering β-Amyloid Accumulation via the Transforming Growth Factor-β (TGFβ)/Smad Signaling Pathway |
| Q44212498 | Interpretation of a BMP activity gradient in Drosophila embryos depends on synergistic signaling by two type I receptors, SAX and TKV. |
| Q40461119 | Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. |
| Q79764829 | Investigation of soluble HER2 and transforming growth factor Beta-1 serum levels in gestational trophoblastic disease |
| Q28584224 | Involvement of Protein Kinase C-Dependent Mitogen-Activated Protein Kinase p44/42 Signaling Pathway for Cross-Talk between Estradiol and Transforming Growth Factor-β3 in Increasing Basic Fibroblast Growth Factor in Folliculostellate Cells |
| Q79077062 | Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas |
| Q40725068 | Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1. |
| Q36235333 | Involvement of pRB family in TGF beta-dependent epithelial cell hypertrophy. |
| Q40960301 | Involvement of protein kinase C and rho GTPase in the nuclear signalling pathway by transforming growth factor-beta1 in rat-2 fibroblast cells |
| Q24304249 | Involvement of the constitutive complex formation of c-Ski/SnoN with Smads in the impaired negative feedback regulation of transforming growth factor beta signaling in scleroderma fibroblasts |
| Q34229030 | Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis |
| Q35107121 | Iron chelation by deferoxamine prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction |
| Q48040710 | Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells |
| Q37431065 | Isolation and characterization of mutant cell lines defective in transforming growth factor beta signaling |
| Q42610052 | Isolation and characterization of novel genes which are expressed during the very early stage of zygote formation in Chlamydomonas reinhardtii |
| Q24337943 | Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells |
| Q36591375 | KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor |
| Q35689725 | Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. |
| Q37558690 | Keratinocyte growth factor functions in epithelial induction during seminal vesicle development |
| Q92225215 | Keratinocyte-derived TGFβ is not required to maintain skin immune homeostasis |
| Q33662935 | LAP degradation product reflects plasma kallikrein-dependent TGF-β activation in patients with hepatic fibrosis |
| Q47884087 | LRP-1/TbetaR-V mediates TGF-beta1-induced growth inhibition in CHO cells |
| Q28362459 | Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells |
| Q34193054 | Latent Transforming Growth Factor-β-binding Protein 2 Is an Adhesion Protein for Melanoma Cells |
| Q47600069 | Latent adenoviral infection induces production of growth factors relevant to airway remodeling in COPD |
| Q24673676 | Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein |
| Q24683923 | Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta |
| Q28238140 | Latent transforming growth factor-beta: structural features and mechanisms of activation |
| Q34622476 | Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3. |
| Q42797261 | Leukoregulin down-regulates type I collagen mRNA levels and promoter activity in human dermal fibroblasts, and counteracts the up-regulation elicited by transforming growth factor-β |
| Q28251546 | Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily |
| Q51129815 | Lipopolysaccharide Activates Toll-Like Receptor 4 and Prevents Cardiac Fibroblast-to-Myofibroblast Differentiation. |
| Q34605980 | Local transposition of a hobo element within the decapentaplegic locus of Drosophila |
| Q82432625 | Localization of Latent Transforming Growth Factor-.BETA. Binding Protein-1 in Human Coronary Atherosclerotic Plaques |
| Q42825447 | Localization of connective tissue growth factor during the period of embryo implantation in the mouse |
| Q54019589 | Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. |
| Q74613731 | Localization of transforming growth factor beta in association with neuromuscular junctions in adult human muscle |
| Q28295393 | Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation |
| Q36744854 | Localization of transforming growth factor-beta 1 in mitochondria of murine heart and liver |
| Q71506738 | Localization of transforming growth factor-beta 1 precursor and latent TGF-beta 1 binding protein in colorectal adenomas |
| Q53278325 | Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization. |
| Q36172870 | Loss of endothelial furin leads to cardiac malformation and early postnatal death |
| Q31861378 | Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) locus predisposes patients to radiation-induced lung injury |
| Q35546848 | Loss of receptors for transforming growth factor beta in human T-cell malignancies. |
| Q30484401 | Loss of transforming growth factor-beta 2 leads to impairment of central synapse function |
| Q33272861 | Low concentrations of transforming growth factor-beta-1 induce tubulogenesis in cultured mammary epithelial cells |
| Q24317247 | MADR1, a MAD-related protein that functions in BMP2 signaling pathways |
| Q40729007 | MEKK1 transduces activin signals in keratinocytes to induce actin stress fiber formation and migration |
| Q34136498 | Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape |
| Q40525136 | Mammalian antiproliferative signals and their targets. |
| Q37378595 | Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth |
| Q40572900 | Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway |
| Q24792405 | Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema |
| Q35743928 | Maternal breast milk transforming growth factor-beta and feeding intolerance in preterm infants |
| Q73712957 | Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies |
| Q36346393 | Mathematical model of TGF-βsignalling: feedback coupling is consistent with signal switching. |
| Q37421682 | Matrix in cartilage and bone development: current views on the function and regulation of major organic components |
| Q86113971 | Matrix metalloproteinase-9, transforming growth factor-β1, and tumor necrosis factor-α plasma levels in chronic pancreatitis |
| Q48191515 | Mechanical Strain Affects Dura Mater Biological Processes: Implications for Immature Calvarial Healing |
| Q47749619 | Mechanical stress induces DNA synthesis in PDL fibroblasts by a mechanism unrelated to autocrine growth factor action |
| Q41101968 | Mechanism of TGFbeta receptor inhibition by FKBP12 |
| Q41734033 | Mechanisms and management of acute renal allograft rejection |
| Q44626931 | Mechanisms in TGF-β Action |
| Q36667816 | Mechanisms of Disease: the role of immune cells in the pathogenesis of systemic sclerosis |
| Q33908049 | Mechanisms of action of cyclosporine. |
| Q33723271 | Medical applications of transforming growth factor-beta |
| Q35773976 | Melanoma-associated expression of transforming growth factor-beta isoforms |
| Q53630145 | Mesangial cells initiate compensatory renal tubular hypertrophy via IL-10-induced TGF-beta secretion: effect of the immunomodulator AS101 on this process. |
| Q55456110 | Mesenchymal Stem Cells Promote Tumor Progression via Inducing Stroma Remodeling on Rabbit VX2 Bladder Tumor Model. |
| Q35567301 | Mesoderm and jaw development in vertebrates: the role of growth factors |
| Q47774284 | Messenger RNA expression of the genes encoding receptors for bone morphogenetic protein (BMP) and transforming growth factor-β (TGF-β) in the cells from the posterior longitudinal ligament in cervical spine |
| Q55478796 | Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas. |
| Q36532275 | Minimal DNA sequences that control the cell lineage-specific expression of the pro alpha 2(I) collagen promoter in transgenic mice |
| Q44505847 | Mitochondrial localization of Smad5 in a human chondrogenic cell line |
| Q38557138 | Modifications of p53 Protein and Accumulation of p21 and gadd45 mRNA in TGF-β1 Growth Inhibited Cells |
| Q34057649 | Modulating conjunctival wound healing |
| Q41140270 | Modulation of insulin-like growth factor-II/mannose 6-phosphate receptors and transforming growth factor-beta 1 during liver regeneration |
| Q72102339 | Modulation of schwann cell phenotype by TGF‐β1: Inhibition of P0 mRNA expression and downregulation of the low affinity NGF receptor |
| Q41893786 | Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury |
| Q39762254 | Modulation of transforming growth factor beta receptor levels on microvascular endothelial cells during in vitro angiogenesis |
| Q77758297 | Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer |
| Q41686589 | Molecular biology of colorectal cancer |
| Q33320234 | Molecular characterization, tissue expression and sequence variability of the barramundi (Lates calcarifer) myostatin gene |
| Q67486909 | Molecular cloning and characterization of a novel rat activin receptor |
| Q33291366 | Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter |
| Q34520144 | Molecular events in gastric carcinogenesis |
| Q36704207 | Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP) |
| Q33969369 | Molecular evolution at the decapentaplegic locus in Drosophila. |
| Q40756547 | Molecular interactions and functional interference between vitronectin and transforming growth factor-beta |
| Q33966655 | Molecular lesions associated with alleles of decapentaplegic identify residues necessary for TGF-beta/BMP cell signaling in Drosophila melanogaster |
| Q35226993 | Molecular mechanisms for generation of neural diversity and specificity: roles of polypeptide factors in development of postmitotic neurons |
| Q37210834 | Molecular mechanisms of thoracic aortic dissection |
| Q37794503 | Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart |
| Q41156035 | Molecular oncology in pancreatic cancer |
| Q34249540 | Molecular regulation of tongue and craniofacial muscle differentiation |
| Q33760306 | Molecular therapy in ocular wound healing |
| Q71524731 | Monocyte production of transforming growth factor beta in long-term hemodialysis: modulation by hemodialysis membranes |
| Q38315485 | Morphogen transport: theoretical and experimental controversies |
| Q47821683 | Morphological and molecular characterization of actinic lentigos reveals alterations of the dermal extracellular matrix. |
| Q36857831 | Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart |
| Q70869035 | Mutagenesis analysis of the membrane-proximal ligand binding site of the TGF-beta receptor type III extracellular domain |
| Q41046801 | Mutational analysis of a transforming growth factor-beta receptor binding site |
| Q40055787 | Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells |
| Q39671621 | Mutations in GDF5 presenting as semidominant brachydactyly A1. |
| Q39446946 | Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway. |
| Q42048024 | Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response |
| Q34005635 | Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia |
| Q36215741 | Myocardin-like protein 2 regulates TGFβ signaling in embryonic stem cells and the developing vasculature. |
| Q28216468 | Myofibroblasts and mechano-regulation of connective tissue remodelling |
| Q38178273 | Myofibroblasts and transforming growth factor-beta1 in reactive gingival overgrowths |
| Q35797870 | Myofibroblasts in experimental hydronephrosis |
| Q24296422 | Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis |
| Q50869684 | Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. |
| Q30477406 | NAC and DTT promote TGF-beta1 monomer formation: demonstration of competitive binding |
| Q41784001 | NMR spectroscopic and bioinformatic analyses of the LTBP1 C-terminus reveal a highly dynamic domain organisation |
| Q74485802 | Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis |
| Q31091914 | Negative growth effectors and cellular senescence |
| Q53676036 | Negative interplay of retinoic acid and TGF-β signaling mediated by TG-interacting factor to modulate mouse embryonic palate mesenchymal-cell proliferation. |
| Q48284817 | Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons |
| Q34883552 | Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons |
| Q42986083 | Neutralization of transforming growth factor beta 1 augments hepatitis C virus-specific cytotoxic T lymphocyte induction in vitro |
| Q36205443 | New developments in the pathogenesis of systemic sclerosis |
| Q37535972 | New era in health care: tissue engineering |
| Q50571787 | New insights into the immunological effects of food bioactive peptides in animal models of intestinal inflammation. |
| Q40547106 | New strategies for treatment of pulmonary fibrosis |
| Q35918951 | Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats |
| Q28504658 | Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation |
| Q34348260 | Nonandrogenic mediators of prostatic growth |
| Q38519494 | Nordihydroguaiaretic acid, an antioxidant, inhibits transforming growth factor-beta activity through the inhibition of Smad signaling pathway. |
| Q38460010 | Nox4 mediates hypoxia-stimulated myofibroblast differentiation in nasal polyp-derived fibroblasts. |
| Q40436356 | Nutrition, Immunology and Cancer: An Overview |
| Q27023170 | Oligomeric interactions of TGF-β and BMP receptors |
| Q36276659 | Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane |
| Q38563398 | Onlay bone augmentation with an osteoinductive implant |
| Q42787892 | Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. |
| Q28573806 | Ontogeny and localization of TGF-beta type I receptor expression during lung development |
| Q33200353 | Opposite Smad and chicken ovalbumin upstream promoter transcription factor inputs in the regulation of the collagen VII gene promoter by transforming growth factor-beta |
| Q41107314 | Opposite effect of stable transfection of bioactive transforming growth factor-beta 1 (TGF beta 1) versus exogenous TGF beta 1 treatment on expression of 92-kDa type IV collagenase in mouse skin squamous cell carcinoma CH72 cells. |
| Q39634749 | Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions |
| Q37348970 | Oral administration of transforming growth factor-β1 (TGF-β1) protects the immature gut from injury via Smad protein-dependent suppression of epithelial nuclear factor κB (NF-κB) signaling and proinflammatory cytokine production |
| Q37337428 | Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression |
| Q40769957 | Osteoinductive proteins |
| Q47124589 | Ovarian function after chemotherapy in young breast cancer survivors |
| Q47804896 | Overexpression and interactions of interleukin-10, transforming growth factor beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma |
| Q40925831 | Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer |
| Q40906841 | Overexpression of a dominant-negative type II TGFbeta receptor tagged with green fluorescent protein inhibits the effects of TGFbeta on cell growth and gene expression of mouse adrenal tumor cell line Y-1 and enhances cell tumorigenicity. |
| Q36502796 | Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia |
| Q54333185 | Oxidative damage and transforming growth factor beta 1 expression in pretumoral and tumoral lesions of human intestine. |
| Q48875855 | Oxidative stress and glaucoma: injury in the anterior segment of the eye. |
| Q39781662 | PDL Progenitor-Mediated PDL Recovery Contributes to Orthodontic Relapse |
| Q28291740 | Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors |
| Q38357026 | Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1. |
| Q34025940 | Pathogenesis of liver fibrosis: role of oxidative stress |
| Q41220098 | Pathogenesis of scleroderma. Collagen |
| Q40570569 | Pattern and regulation of cell proliferation during murine ureteric bud development |
| Q52229149 | Pattern of expression of transforming growth factor‐β4 mRNA and protein in the developing chicken embryo |
| Q33708971 | Peptide ligands that use a novel binding site to target both TGF-β receptors. |
| Q71808066 | Peptidergic, catecholaminergic and morphological properties of avian chromaffin cells are modulated distinctively by growth factors |
| Q50512238 | Peripheral retinopathy in offspring of carriers of Norrie disease gene mutations. Possible transplacental effect of abnormal Norrin. |
| Q72463216 | Peritoneal macrophages show increased cytokine gene expression following haemorrhagic shock |
| Q40803721 | Persistence of TGF-beta1 induction of increased fibroblast contractility |
| Q46156939 | Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats |
| Q24678822 | Pharmacotherapy and airway remodelling in asthma? |
| Q80962311 | Phenotype and function of a CD56+ peripheral blood monocyte |
| Q28344659 | Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation |
| Q34289975 | Phosphoprotein abundance changes in hypertensive cardiac remodeling |
| Q36415867 | Phosphorylation of bone morphogenetic protein-15 and growth and differentiation factor-9 plays a critical role in determining agonistic or antagonistic functions |
| Q33566799 | Plasma TGF beta in systemic sclerosis: a cross-sectional study. |
| Q44863746 | Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens |
| Q41901900 | Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface |
| Q87912119 | Platelet TGF-β1 deficiency decreases liver fibrosis in a mouse model of liver injury |
| Q34328539 | Platelet-derived growth factor and transforming growth factor-beta in invertebrate immune and neuroendocrine interactions: another sign of conservation in evolution |
| Q40841517 | Pleiotropic effects of transforming growth factor-beta on cells of the immune system |
| Q80340215 | Pleomorphic adenoma and adenoid cystic carcinoma: in vitro study of the impact of TGFbeta1 on the expression of integrins and cytoskeleton markers of cell differentiation |
| Q41595835 | Polypeptide growth factors: targeted delivery systems |
| Q41925049 | Polypeptide hormone degradation and receptor regulation are coupled to ligand internalization. A direct biochemical and morphologic demonstration |
| Q35023540 | Positive selection in bone morphogenetic protein 15 targets a natural mutation associated with primary ovarian insufficiency in human |
| Q40967869 | Preferential enhancement of B cell IgA secretion by intestinal epithelial cell-derived cytokines and interleukin-2. |
| Q40600748 | Preparation and identification of anti-transforming growth factor beta1 U1 small nuclear RNA chimeric ribozyme in vitro |
| Q73867368 | Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage |
| Q40277998 | Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene |
| Q35568909 | Prodomain removal enables neto to stabilize glutamate receptors at the Drosophila neuromuscular junction |
| Q73807095 | Production of neuropeptide substance P by synovial fibroblasts from patients with rheumatoid arthritis and osteoarthritis |
| Q41094480 | Programmed cell death and cell transformation in craniofacial development |
| Q41602632 | Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes |
| Q48631630 | Proliferative genes induce somatic pairing defects in Drosophila melanogaster and allow replication |
| Q38859036 | Prostaglandin E2 increases proximal tubule fluid reabsorption, and modulates cultured proximal tubule cell responses via EP1 and EP4 receptors |
| Q35547017 | Prostate Development and Carcinogenesis |
| Q89478607 | Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats |
| Q36708700 | Protein kinase A modulates transforming growth factor-β signaling through a direct interaction with Smad4 protein |
| Q47429879 | Purification of a new type high molecular weight receptor (type V receptor) of transforming growth factor beta (TGF-beta) from bovine liver. Identification of the type V TGF-beta receptor in cultured cells |
| Q28568024 | Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan |
| Q42548839 | Quantitative Relationship Between Transforming Growth Factor-Alpha and Hepatic Focal Phenotype and Progression in Female Mouse Liver |
| Q61654350 | Quantitative analysis of PDGFA, PDGFB, PDGF receptor β and TGF-β1 mRNA in cardiac transplant biopsies |
| Q36668975 | RNA fingerprinting using arbitrarily primed PCR identifies differentially regulated RNAs in mink lung (Mv1Lu) cells growth arrested by transforming growth factor beta 1 |
| Q41386240 | RRR-alpha-tocopheryl succinate inhibits DNA synthesis and enhances the production and secretion of biologically active transforming growth factor-beta by avian retrovirus-transformed lymphoid cells |
| Q41386256 | RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways |
| Q37430721 | Rac1 promotes TGF-beta-stimulated mesangial cell type I collagen expression through a PI3K/Akt-dependent mechanism. |
| Q36899203 | Radiographic Assessment of Bone Formation Using rhBMP2 at Maxillary Periapical Surgical Defects: A Case Series |
| Q36618020 | Rapid induction of p21WAF1 but delayed down-regulation of Cdc25A in the TGF-beta-induced cell cycle arrest of gastric carcinoma cells |
| Q33604483 | Reactive microgliosis |
| Q24292866 | Reactive oxygen species mediates the apoptosis induced by transforming growth factor beta(2) in human lens epithelial cells |
| Q41657233 | Recent advances in the treatment of malignant melanoma with gene therapy |
| Q72035474 | Receptor binding of transforming growth factor-β by human fetal adrenal cells |
| Q72756805 | Receptors for the TGF-beta ligand family |
| Q56975257 | Recombinant IFN-γ abrogates allograft tolerance induced by donor-specific blood transfusion by restoring alloantibody production |
| Q36532421 | Recombinant human bone morphogenetic protein 2B stimulates PC12 cell differentiation: potentiation and binding to type IV collagen |
| Q52203438 | Recombinant human growth/differentiation factor 5 stimulates mesenchyme aggregation and chondrogenesis responsible for the skeletal development of limbs. |
| Q64987991 | Recombinant production, purification, crystallization, and structure analysis of human transforming growth factor β2 in a new conformation. |
| Q28360679 | Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent |
| Q37639003 | Reconstitution and transphosphorylation of TGF-beta receptor complexes |
| Q40680736 | Reconstitution of Smad3 restores TGF-beta response of tissue inhibitor of metalloprotease-1 upregulation in human choriocarcinoma cells |
| Q41193401 | Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II, III receptor in baculoviral-infected insect cells |
| Q71302847 | Recovery phase of acute experimental autoimmune encephalomyelitis in rats corresponds to development of endothelial cell unresponsiveness to interferon gamma activation |
| Q53398201 | Reducing mammary cancer risk through premature stem cell senescence. |
| Q40211671 | Reduction of invasive potential in K-ras-transformed thyroid cells by restoring of TGF-beta pathway |
| Q77367217 | Regressive changes in finasteride-treated human hyperplastic prostates correlate with an upregulation of TGF-beta receptor expression |
| Q24529895 | Regulation of TG-interacting factor by transforming growth factor-beta |
| Q52213986 | Regulation of TGF beta 3 gene expression in embryonic palatal tissue. |
| Q42494694 | Regulation of activin A, inhibin A, and follistatin production in human amnion and choriodecidual explants by inflammatory mediators |
| Q47702574 | Regulation of activin-A production by human amnion, decidua and placenta in vitro by pro-inflammatory cytokines |
| Q42070047 | Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta |
| Q41648060 | Regulation of amphiregulin mRNA by TGF-beta in the human lung adenocarcinoma cell line A549 |
| Q46302667 | Regulation of astrocyte GFAP expression by TGF-beta1 and FGF-2. |
| Q77582000 | Regulation of chondrocyte differentiation and maturation |
| Q58047195 | Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts |
| Q40468537 | Regulation of connective tissue synthesis in systemic sclerosis. |
| Q41648556 | Regulation of expression of transforming growth factor-beta 2 by transforming growth factor-beta isoforms is dependent upon cell type |
| Q24651506 | Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors |
| Q67765307 | Regulation of integrin-type cell adhesion receptors by cytokines |
| Q72633788 | Regulation of mRNA transcripts and DNA synthesis in the rat heart following intravenous injection of transforming growth factor beta 1 |
| Q52014392 | Regulation of murine TGFbeta2 by Pax3 during early embryonic development. |
| Q41947979 | Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells |
| Q40998070 | Regulation of prostatic growth and function by peptide growth factors |
| Q43713644 | Regulation of telomerase during human placental differentiation: a role for TGFbeta1. |
| Q34208686 | Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes |
| Q73396244 | Regulation of transforming growth factor-beta production by interleukin-12 |
| Q78251607 | Regulation of transforming growth factor-beta, basic fibroblast growth factor, and vascular endothelial cell growth factor mRNA in peripheral blood leukocytes in patients with diabetic retinopathy |
| Q53998721 | Relationship between grade of microsatellite instability and target genes of mismatch repair pathways in sporadic colorectal carcinoma. |
| Q71803700 | Release and activation of platelet latent TGF–β in blood clots during dissolution with plasmin |
| Q38307585 | Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency |
| Q36404409 | Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait |
| Q36449993 | Resolution of immune response by recombinant transforming growth factor-beta (rTGF-β) during influenza A virus infection |
| Q40723721 | Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells |
| Q73378753 | Retinoic acid down-regulates VPAC(1) receptors and TGF-beta 3 but up-regulates TGF-beta 2 in lung cancer cells |
| Q24635194 | Review of the activation of TGF-beta in immunity |
| Q41698429 | Review: analogies between trophoblastic and malignant cells |
| Q46127963 | Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion |
| Q40110631 | Role of RGM coreceptors in bone morphogenetic protein signaling |
| Q35937392 | Role of TGF-beta 1 and TGF-beta type II receptor in gastric cancer |
| Q40903711 | Role of TGF-beta in EGF-induced transformation of NRK cells is sustaining high-level EGF-signaling |
| Q37959379 | Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects |
| Q47096314 | Role of Transforming Growth Factor β in Uterine Fibroid Biology |
| Q33843497 | Role of cytokines in the pathogenesis of posterior capsule opacification |
| Q34263687 | Role of growth factors and their receptors in gastric ulcer healing. |
| Q44700302 | Role of growth factors in the developmental regulation of the human fetal adrenal cortex |
| Q38299886 | Role of inflammatory cytokines in peripheral nerve injury |
| Q42919024 | Role of microsomal prostaglandin E synthase-1 in the facilitation of angiogenesis and the healing of gastric ulcers |
| Q40488258 | Role of peptide growth factors in the prostate: A review |
| Q40424212 | Role of platelets in progressive glomerular diseases |
| Q70616847 | Role of proteoglycans and cytoskeleton in the effects of TGF-beta 1 on renal proximal tubule cells |
| Q35023097 | Role of steroid hormones and growth factors in breast cancer |
| Q33964689 | Role of the IkappaB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells |
| Q33892994 | Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling. |
| Q36383054 | Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells |
| Q71848570 | Role of the transforming growth factor‐β family in the expression of cranial neural crest‐specific phenotypes |
| Q40794752 | Role of transforming growth factor beta (TGF beta) in systemic autoimmunity |
| Q41036100 | Role of transforming growth factor beta 1 (TGF beta 1) in mediating androgen-induced growth inhibition in human adrenal cortex in vitro |
| Q39658951 | Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases |
| Q35721985 | Role of transforming growth factor beta in breast carcinogenesis |
| Q40856616 | Role of transforming growth factor beta in colorectal cancer |
| Q35019137 | Role of transforming growth factor beta in ovarian surface epithelium biology and ovarian cancer |
| Q77807982 | Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats |
| Q42049704 | Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver disease |
| Q35609202 | Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1 |
| Q34136505 | Role of transforming growth factor-beta1 in prostate cancer |
| Q43615424 | Roles of Ets proteins, NF-kappa B and nocodazole in regulating induction of transcription of mouse germline Ig alpha RNA by transforming growth factor-beta 1. |
| Q33923757 | Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis |
| Q46511537 | Roxithromycin reduces cyclosporine-induced gingival hyperplasia in renal transplant patients |
| Q33966602 | Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. |
| Q40524192 | SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. |
| Q48282075 | SMAD7 deficiency stimulates Müller progenitor cell proliferation during the development of the mammalian retina |
| Q33247465 | Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene |
| Q39808932 | Schlafen-3: a novel regulator of intestinal differentiation |
| Q44341339 | Scleroderma dermal fibroblasts overexpress vascular endothelial growth factor due to autocrine transforming growth factor β signaling |
| Q36067741 | Scleroderma, fibroblasts, signaling, and excessive extracellular matrix |
| Q52289614 | Second-trimester dimeric inhibin-A in Down's syndrome screening. |
| Q78016981 | Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia |
| Q34068785 | Secretion and mesoderm-inducing activity of the TGF-beta-related domain of Xenopus Vg1. |
| Q72798590 | Selective inactivity of TGF-beta/decorin complexes |
| Q40950625 | Seminal transforming growth factor-beta in normal and infertile men. |
| Q73563616 | Sequence-specific 1H and 15N assignment and secondary structure of transforming growth factor beta3 |
| Q53616997 | Serum anti-Müllerian hormone levels do not predict the efficiency of testicular sperm retrieval in men with non-obstructive azoospermia. |
| Q36929756 | Serum cytokine levels in patients with Alzheimer's disease |
| Q41807262 | Serum factors, growth factors and UDP-sugar metabolism in bovine articular cartilage chondrocytes |
| Q73131344 | Sex- and age-related temporal variations in intestinal-epithelium proliferation in the suckling mouse |
| Q41179943 | Signal transduction and TGF-beta superfamily receptors |
| Q28303118 | Signal transduction by members of the transforming growth factor-beta superfamily |
| Q36826768 | Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region |
| Q35091405 | Signaling and transcriptional control of Fas ligand gene expression. |
| Q53597450 | Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. |
| Q40423643 | Significance of angiogenesis in tumour progression and metastasis |
| Q40566806 | Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells |
| Q28608955 | Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta |
| Q28608960 | SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling |
| Q28304684 | SnoN is a cell type-specific mediator of transforming growth factor-beta responses |
| Q36058887 | SnoN signaling in proliferating cells and postmitotic neurons |
| Q45865268 | Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats |
| Q50661031 | Soluble betaglycan reduces renal damage progression in db/db mice. |
| Q40537891 | Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. |
| Q40911869 | Spatial Engineering of Osteochondral Tissue Constructs Through Microfluidically Directed Differentiation of Mesenchymal Stem Cells |
| Q35123221 | Spatial control of cell fate using synthetic surfaces to potentiate TGF-beta signaling |
| Q46883210 | Species differences in hepatic peroxisome proliferation, cell replication and transforming growth factor-beta1 gene expression in the rat, Syrian hamster and guinea pig. |
| Q38299643 | Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-beta1. |
| Q33969420 | Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice |
| Q72590542 | Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression |
| Q43618724 | Spontaneous cytokine gene expression in normal guinea pig blood and tissues |
| Q41102304 | Stabilization of elastin mRNA by TGF-beta: initial characterization of signaling pathway |
| Q41764890 | Stimulation of Superficial Zone Protein/Lubricin/PRG4 by Transforming Growth Factor-β in Superficial Zone Articular Chondrocytes and Modulation by Glycosaminoglycans |
| Q77333940 | Stimulation of the dentine-pulp complex of rat incisor teeth by transforming growth factor-beta isoforms 1-3 in vitro |
| Q38299646 | Stimulation of transforming growth factor-beta 1 transcription by cyclosporine |
| Q35603412 | Strong expression of TGF-beta in human host tissues around subcutaneous Dirofilaria repens |
| Q41256244 | Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide |
| Q77360649 | Structural determinants of binding and specificity in transforming growth factor-receptor interactions |
| Q67476492 | Structure, Function and Possible Clinical Application of Transforming Growth Factor‐β |
| Q42551215 | Structures of a pan-specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody-antigen interactions |
| Q67485868 | Subtypes of betaglycan and of type I and type II transforming growth factor‐β (TGF‐β) receptors with different affinities for TGF‐β1 and TGF‐β2 are exhibited by human placental trophoblast cells |
| Q58764105 | Subversion of Cytokine Networks by Viruses |
| Q33805908 | Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases |
| Q40615978 | Suppressin: an endogenous negative regulator of immune cell activation |
| Q33754416 | Suppression of TGFβ-induced epithelial-mesenchymal transition like phenotype by a PIAS1 regulated sumoylation pathway in NMuMG epithelial cells |
| Q44467491 | Suramin modulates wound healing of rabbit conjunctiva after trabeculectomy: comparison with mitomycin C. |
| Q39259601 | Surfactant protein A influences reepithelialization in an alveolocapillary model system |
| Q28209016 | Survival and cell cycle control in early hematopoiesis: role of bcl-2, and the cyclin dependent kinase inhibitors P27 and P21 |
| Q35555416 | Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms |
| Q42057123 | Synergy between TGF-beta and anti-IgM in growth inhibition of CD5+ B-cell lymphomas |
| Q35398178 | Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor beta 1 knockout mice |
| Q40634530 | Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD. |
| Q35762583 | Systemic administration of transforming growth factor-beta 2 prevents the impaired bone formation and osteopenia induced by unloading in rats |
| Q73251004 | TGF beta 1 induces growth arrest and apoptosis but not ciliated cell differentiation in rat tracheal epithelial cell cultures |
| Q28287007 | TGF beta 1 inhibits NF-kappa B/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappa B alpha |
| Q46033313 | TGF beta inhibits rat thyroid cell proliferation without alterations in the expression of TSH-induced cell cycle-related genes |
| Q24337608 | TGF beta signals through a heteromeric protein kinase receptor complex |
| Q40682680 | TGF beta-1 downregulates DMP-1 and DSPP in odontoblasts |
| Q73874803 | TGF beta1 induces multiple independent signals to regulate human trophoblastic differentiation: mechanistic insights |
| Q28587575 | TGF-beta 1 inhibits mast cell Fc epsilon RI expression |
| Q36530713 | TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector |
| Q46491991 | TGF-beta 1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expression |
| Q44510309 | TGF-beta 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension |
| Q47968161 | TGF-beta and PDGF act synergistically in affecting the growth of human osteoblast-enriched cultures |
| Q46183867 | TGF-beta and phorbol esters inhibit mitogenesis utilizing parallel protein kinase C-dependent pathways |
| Q24814883 | TGF-beta expression during rat pregnancy and activity on decidual cell survival |
| Q70660049 | TGF-beta gene expression depends on tissue architecture |
| Q33857618 | TGF-beta in blood: a complex problem |
| Q33890533 | TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway |
| Q73044314 | TGF-beta receptor expression in human odontoblasts and pulpal cells |
| Q77123783 | TGF-beta receptor expression on human keratinocytes: a 150 kDa GPI-anchored TGF-beta1 binding protein forms a heteromeric complex with type I and type II receptors |
| Q41659039 | TGF-beta receptor signaling |
| Q33828926 | TGF-beta receptors and DNA repair genes, coupled targets in a pathway of human colon carcinogenesis |
| Q35969335 | TGF-beta signal transduction in oro-facial health and non-malignant disease (part I). |
| Q40941798 | TGF-beta(1), regulation of alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization |
| Q41688258 | TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor |
| Q34057799 | TGF-beta-based immunotherapy for cancer: breaching the tumor firewall |
| Q24291517 | TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation |
| Q71388110 | TGF-beta-induced apoptosis of cerebellar granule neurons is prevented by depolarization |
| Q36926151 | TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein |
| Q54520096 | TGF-beta1 and IGF-1 and anastomotic recurrence of Crohn's disease after ileo-colonic resection. |
| Q33913350 | TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? |
| Q36441377 | TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia |
| Q39737677 | TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. |
| Q79954713 | TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study |
| Q41814463 | TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing |
| Q28511171 | TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion |
| Q36772774 | TGF-beta: problems and prospects |
| Q52204225 | TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo. |
| Q64111400 | TGF-β Has a Role in Survival in the Vector |
| Q47632031 | TGF-β and IL-6 family signalling crosstalk: an integrated model |
| Q34798852 | TGF-β and restenosis revisited: a Smad link |
| Q92883776 | TGF-β family ligands exhibit distinct signalling dynamics that are driven by receptor localisation |
| Q39324100 | TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota |
| Q36458347 | TGF-β in tolerance, development and regulation of immunity |
| Q35179134 | TGF-β stimulation in human and murine cells reveals commonly affected biological processes and pathways at transcription level |
| Q88389134 | TGF-β-target genes are differentially regulated in corneal epithelial cells and fibroblasts |
| Q50483893 | TGF-β1 monoclonal antibody: Assessment of embryo-fetal toxicity in rats and rabbits. |
| Q36202713 | TGF-β1 stimulates movement of renal proximal tubular epithelial cells in a three-dimensional cell culture via an autocrine TGF-β2 production |
| Q38991532 | TGF-β1-induced expression of Id-1 is associated with tumor progression in gastric cancer |
| Q54581283 | TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. |
| Q37610135 | TGFBR1 is required for mouse myometrial development |
| Q24320125 | TGFbeta-Smad signalling in postoperative human lens epithelial cells |
| Q35079897 | TGFbeta-induced fibrogenesis of the pancreas |
| Q37366054 | TGFbeta1 regulates gene expression of its own converting enzyme furin |
| Q40852902 | TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation |
| Q74602782 | TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103 |
| Q28592444 | TGFβ2 knockout mice have multiple developmental defects that are non-overlapping with other TGFβ knockout phenotypes |
| Q40649955 | TGF‐β1 modulates Fas (APO‐1/CD95)‐mediated apoptosis of human pre‐B cell lines |
| Q33890489 | TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth. |
| Q41505601 | TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion |
| Q46256864 | Tamoxifen decreases extracellular TGF-beta1 secreted from breast cancer cells--a post-translational regulation involving matrix metalloproteinase activity |
| Q42812463 | Tamoxifen decreases the rate of proliferation of rat vascular smooth-muscle cells in culture by inducing production of transforming growth factor beta |
| Q39445051 | Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction |
| Q28202655 | Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease |
| Q24301138 | Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells |
| Q36565055 | Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy |
| Q34050002 | Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. |
| Q36235014 | Tenascin-C expression by fibroblasts is elevated in stressed collagen gels |
| Q40571488 | Terminal differentiation of Sol 8 myoblasts is retarded by a transforming growth factor-beta autocrine regulatory loop |
| Q38168211 | Tgf-Beta family signaling in embryonic stem cells. |
| Q36083442 | Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. |
| Q28276556 | The Discovery and Early Days of TGF-β: A Historical Perspective |
| Q37627176 | The Drosophila segment polarity gene patched interacts with decapentaplegic in wing development. |
| Q36985643 | The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis |
| Q35870737 | The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site |
| Q37052226 | The Interplay between the bone and the immune system |
| Q40762449 | The Mad1 transcription factor is a novel target of activin and TGF-beta action in keratinocytes: possible role of Mad1 in wound repair and psoriasis |
| Q28216325 | The RFX family interacts at the collagen (COL1A2) start site and represses transcription |
| Q36518216 | The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy |
| Q26825633 | The Review on Properties of Aloe Vera in Healing of Cutaneous Wounds |
| Q22253316 | The Smad pathway |
| Q38784881 | The TGF-β Signalling Network in Muscle Development, Adaptation and Disease. |
| Q64910548 | The Wound Healing Effect of Callicarpa nudiflora in Scalded Rats. |
| Q34120038 | The ability of mineral dusts and fibres to initiate lipid peroxidation. Part II: relationship to different particle-induced pathological effects |
| Q41049350 | The anti-proliferative effect of suramin towards tamoxifen-sensitive and resistant human breast cancer cell lines in relation to expression of receptors for epidermal growth factor and insulin-like growth factor-I: growth stimulation in the presence |
| Q36846125 | The bone morphogenetic protein 1/Tolloid-like metalloproteinases |
| Q40733277 | The cell cycle and the retinoblastoma protein family |
| Q33610876 | The cellular and molecular basis of prostate cancer |
| Q24674065 | The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding |
| Q51750855 | The cyclin kinase inhibitor p57kip2 regulates TGF-beta-induced compensatory tubular hypertrophy: effect of the immunomodulator AS101. |
| Q36553088 | The decapentaplegic core promoter region plays an integral role in the spatial control of transcription |
| Q41685485 | The disulfide bond arrangement in the extracellular domain of the activin type II receptor |
| Q41145976 | The effect of TGF-beta 1 on cell proliferation and proteoglycan production in human melanoma cells depends on the degree of cell differentiation |
| Q38122314 | The effect of TGF-β1 polymorphism on systemic sclerosis: a systematic review and pooled analysis of available literature |
| Q77362713 | The effect of transforming growth factor and interleukin-10 on interleukin-8 release by human amniochorion may regulate histologic chorioamnionitis |
| Q72410238 | The effects of T cells and their products on in vitro healing of epitenon cell microwounds |
| Q71833964 | The extracts from rat submandibular glands induce the erythroid differentiation of K-562 CELLS |
| Q55118838 | The function of bone morphogenetic proteins in the human ovary. |
| Q28291207 | The generation of diversity and pattern in animal development |
| Q50742524 | The genotype and expression of the TGFβ2 gene in children with congenital conotruncal defects. |
| Q41477305 | The immortalized astroglial cell line RC7 is a new model system for the study of nerve growth factor (NGF) regulation: stimulation by interleukin-1 beta and transforming growth factor-beta 1 is additive and affected differently by dibutyryl cyclic A |
| Q73195089 | The immunohistochemical localization of transforming growth factor-beta 2 in the fetal and neonatal rat testis |
| Q34466916 | The influence of growth factors on the development of preimplantation mammalian embryos |
| Q41281184 | The integrated processes of hard tissue regeneration with special emphasis on fracture healing |
| Q24535009 | The integrin alphavbeta3 is a receptor for the latency-associated peptides of transforming growth factors beta1 and beta3 |
| Q36631237 | The integrin-coupled signaling adaptor p130Cas suppresses Smad3 function in transforming growth factor-beta signaling |
| Q72543626 | The involvement of TGF beta 1 in early avian development: gastrulation and chondrogenesis |
| Q24532213 | The latent transforming growth factor beta binding protein (LTBP) family |
| Q52200075 | The liver in transforming growth factor-Beta-1 (TGF-beta 1) null mutant mice. |
| Q48158504 | The loss of E-cadherin mRNA transcripts in rat prostatic tumors is accompanied by increased expression of mRNA transcripts encoding fibronectin and its receptor |
| Q42770338 | The mechanism for the activation of latent TGF-beta during co-culture of endothelial cells and smooth muscle cells: cell-type specific targeting of latent TGF-beta to smooth muscle cells |
| Q40853576 | The mechanism of action of transforming growth factor-beta. |
| Q57697307 | The mutational spectrum of brachydactyly type C |
| Q36649630 | The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells |
| Q28276517 | The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3 |
| Q36612601 | The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer |
| Q70497297 | The release of transforming growth factor-beta following haemorrhage: its role as a mediator of host immunosuppression |
| Q41029861 | The role of BMPs and GDFs in development of region-specific skeletal structures |
| Q48170058 | The role of TGF-beta signaling in dendritic cell tolerance |
| Q22008646 | The role of activin type I receptors in activin A-induced growth arrest and apoptosis in mouse B-cell hybridoma cells |
| Q29040166 | The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy |
| Q34278051 | The role of anti-Müllerian hormone in female fertility and infertility - an overview |
| Q38209671 | The role of epigenetics in the fibrotic processes associated with glaucoma. |
| Q70587105 | The role of fibronectin in tumor implantation at surgical sites |
| Q41530670 | The role of growth regulatory aberrations in progression of human colon carcinoma |
| Q37423754 | The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. |
| Q70680946 | The role of protein tyrosine phosphatases in density-dependent growth control of normal rat kidney cells |
| Q36038023 | The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. |
| Q40232314 | The role of the activin system in keloid pathogenesis. |
| Q36363932 | The role of transforming growth factor beta in the generation of suppression: an interaction between CD8+ T and NK cells |
| Q24809655 | The role of transforming growth factor-beta (TGF-beta) during ovarian follicular development in sheep |
| Q40795836 | The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production |
| Q33781412 | The role of transforming growth factor-beta in transplant rejection |
| Q41054374 | The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells |
| Q36726631 | The screw gene encodes a ubiquitously expressed member of the TGF-beta family required for specification of dorsal cell fates in the Drosophila embryo |
| Q44945496 | The serine protease HtrA1 is upregulated in the human placenta during pregnancy. |
| Q24313061 | The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands |
| Q52148803 | The temporal expression patterns of fibronectin and its receptors-α5β1 and αvβ3 integrins on blood vessels after cerebral ischemia. |
| Q28631127 | The transforming growth factor beta receptors types I, II, and III form hetero-oligomeric complexes in the presence of ligand |
| Q40916097 | The transforming growth factor beta(1)-inducible transcription factor TIEG1, mediates apoptosis through oxidative stress |
| Q34083587 | The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions |
| Q40519781 | The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex |
| Q45242443 | Therapeutic effect of the immunomodulator glatiramer acetate on trinitrobenzene sulfonic acid-induced experimental colitis |
| Q48933640 | Three mutant genes cooperatively induce brain tumor formation in Drosophila malignant brain tumor |
| Q36024744 | Thrombospondin-1 inhibits osteogenic differentiation of human mesenchymal stem cells through latent TGF-β activation |
| Q28513856 | Thrombospondin-1 is a major activator of TGF-beta1 in vivo |
| Q40598570 | Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta |
| Q44560324 | Toluene inhalation induces glial cell line-derived neurotrophic factor, transforming growth factor and tumor necrosis factor in rat cerebellum |
| Q53167359 | Topical estradiol does not interfere with the expression of the metalloproteinase-1 enzyme in photo exposed skin cells. |
| Q40686388 | Transcriptional activation of collagenase-3 by transforming growth factor-beta1 is via MAPK and Smad pathways in human breast cancer cells. |
| Q40911298 | Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer |
| Q36127847 | Transcriptome response to heat stress in a chicken hepatocellular carcinoma cell line |
| Q37147106 | Transdifferentiation of alveolar epithelial type II to type I cells is controlled by opposing TGF-β and BMP signaling |
| Q46271150 | Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer. |
| Q70966187 | Transfer of a mutated gene encoding active transforming growth factor-beta 1 suppresses mitogenesis and IL-1 response in the glomerulus |
| Q38289403 | Transforming Growth Factor β Activates the Promoter of Cyclin-dependent Kinase Inhibitor p15 through an Sp1 Consensus Site |
| Q71970379 | Transforming Growth Factor-Beta Receptors and Mannose 6-Phosphate/Insulin-Like Growth Factor-II Receptor Expression in Human Hepatocellular Carcinoma |
| Q42469829 | Transforming Growth Factor-ß Regulates Basal Expression of the hsp70 Gene Family in Cultured Chicken Embryo Cells |
| Q44117426 | Transforming growth factor (TGF)-β signalling is increased in rheumatoid synovium but TGF-β blockade does not modify experimental arthritis |
| Q34460888 | Transforming growth factor Beta 3 is required for excisional wound repair in vivo |
| Q35076034 | Transforming growth factor Beta family: insight into the role of growth factors in regulation of fracture healing biology and potential clinical applications. |
| Q71131479 | Transforming growth factor beta (TGF-beta) expression in isolated and cultured rat hepatocytes |
| Q37373014 | Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity |
| Q36230076 | Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia |
| Q42467495 | Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma |
| Q33604693 | Transforming growth factor beta 1 gene expression in human airways |
| Q70998049 | Transforming growth factor beta 1 induces mitogenesis in fetal rat brown adipocytes |
| Q24563654 | Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death |
| Q42831887 | Transforming growth factor beta 1, insulin and prostaglandin E1 enhance prostaglandin F2 alpha mitogenic action in Swiss 3T3 cells via separate events |
| Q71993035 | Transforming growth factor beta 1-hyaluronic acid interaction |
| Q33578340 | Transforming growth factor beta 2 in labial salivary glands in Sjögren's syndrome |
| Q71646348 | Transforming growth factor beta I expression in benign and malignant prostatic tumors |
| Q41854472 | Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site |
| Q35236513 | Transforming growth factor beta and interleukin-1: a paradigm for opposing regulation of haemopoiesis |
| Q34136484 | Transforming growth factor beta and mouse development |
| Q46569445 | Transforming growth factor beta and progression of renal disease |
| Q40801234 | Transforming growth factor beta and the cell surface in tumor progression |
| Q42026748 | Transforming growth factor beta decreases the rate of proliferation of rat vascular smooth muscle cells by extending the G2 phase of the cell cycle and delays the rise in cyclic AMP before entry into M phase |
| Q36646526 | Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases |
| Q37047765 | Transforming growth factor beta induces myoblast differentiation in the presence of mitogens |
| Q34235866 | Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism |
| Q33490828 | Transforming growth factor beta isoforms regulation of Akt activity and XIAP levels in rat endometrium during estrous cycle, in a model of pseudopregnancy and in cultured decidual cells |
| Q41391410 | Transforming growth factor beta s and wound healing |
| Q36691246 | Transforming growth factor beta secretion from primary breast cancer fibroblasts |
| Q33930282 | Transforming growth factor beta signaling mediators and modulators |
| Q41650318 | Transforming growth factor beta stimulates mitogenically mouse NIH3T3 fibroblasts and those cells transformed by the EJ-H ras oncogene |
| Q39631154 | Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity |
| Q36387492 | Transforming growth factor beta upregulates 5-lipoxygenase activity during myeloid cell maturation |
| Q41195628 | Transforming growth factor beta-1 and beta-2 in human tear fluid |
| Q28367243 | Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression |
| Q35866322 | Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes |
| Q28582231 | Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells |
| Q36367920 | Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc |
| Q42442703 | Transforming growth factor beta1 inhibits steroidogenesis in dispersed fetal testicular cells in culture |
| Q40933380 | Transforming growth factor beta2 is able to modify mRNA levels and release of luteinizing hormone-releasing hormone in a immortalized hypothalamic cell line (GT1-1). |
| Q28566396 | Transforming growth factor beta2 is released from PC12 cells via the regulated pathway of secretion |
| Q33801290 | Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas |
| Q36362204 | Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha? |
| Q40405722 | Transforming growth factor beta: relevance to radiotherapy |
| Q77373481 | Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma |
| Q40430362 | Transforming growth factor β and cancer |
| Q36349565 | Transforming growth factor β inhibitor Repsox down-regulates collagen expression of scleroderma dermal fibroblasts and prevents bleomycin-induced mice skin fibrosis. |
| Q28583952 | Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts |
| Q36242096 | Transforming growth factor-beta (TGF-beta) and programmed cell death in the vertebrate retina |
| Q36745193 | Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta |
| Q78015579 | Transforming growth factor-beta (TGF-beta) type I and type II receptors are both required for TGF-beta-mediated extracellular matrix production in lung fibroblasts |
| Q41282869 | Transforming growth factor-beta (TGF-beta)-induced down-regulation of cyclin A expression requires a functional TGF-beta receptor complex. Characterization of chimeric and truncated type I and type II receptors |
| Q41505517 | Transforming growth factor-beta 1 enhances serum-induced dephosphorylation of the P53 protein in cell lines growth-inhibited by this factor |
| Q35113482 | Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage |
| Q72188503 | Transforming growth factor-beta 1 inhibits TCDD-induced cytochrome P450IA1 expression in human lung cancer A549 cells |
| Q41653372 | Transforming growth factor-beta 1 inhibits scavenger receptor activity in THP-1 human macrophages |
| Q35832956 | Transforming growth factor-beta 1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. |
| Q40682198 | Transforming growth factor-beta 1 mutations in Camurati-Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein |
| Q35797879 | Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders |
| Q67554743 | Transforming growth factor-beta 1 rapidly activates phosphorylase in a calcium-dependent manner in rat hepatocytes |
| Q28364695 | Transforming growth factor-beta 1 stimulates vascular smooth muscle cell L-proline transport by inducing system A amino acid transporter 2 (SAT2) gene expression |
| Q28591637 | Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression |
| Q40732071 | Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor |
| Q73169856 | Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance To central fatigue |
| Q24793291 | Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer |
| Q41442972 | Transforming growth factor-beta and prostate cancer. |
| Q36457999 | Transforming growth factor-beta and the immune system |
| Q24642789 | Transforming growth factor-beta complexes with thrombospondin |
| Q23911046 | Transforming growth factor-beta following skeletal muscle strain injury in rats |
| Q73287222 | Transforming growth factor-beta gene expression in normal and fibrotic rat liver |
| Q42772810 | Transforming growth factor-beta gene expression studies in nasal mucosal biopsies in naturally occurring allergic rhinitis |
| Q52228214 | Transforming growth factor-beta in the early mouse embryo: implications for the regulation of muscle formation and implantation. |
| Q27919635 | Transforming growth factor-beta induces secretion of activated ADAMTS-2. A procollagen III N-proteinase |
| Q46294575 | Transforming growth factor-beta inhibition of mineralization by neonatal rat osteoblasts in monolayer and collagen gel culture |
| Q40662685 | Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest. |
| Q48004205 | Transforming growth factor-beta isoform expression in human ovarian tumours |
| Q73937167 | Transforming growth factor-beta isoform expression in mature human healthy and carious molar teeth |
| Q53878416 | Transforming growth factor-beta isoforms differently stimulate proalpha2 (I) collagen gene expression during wound healing process in transgenic mice. |
| Q52195891 | Transforming growth factor-beta isoforms in the developing chicken intestine and spleen: increase in transforming growth factor-beta 4 with coccidia infection. |
| Q73262569 | Transforming growth factor-beta localization during mouse prostate morphogenesis and in prostatic growth abnormalities |
| Q42456770 | Transforming growth factor-beta opposes the stimulatory effects of interleukin-1 and tumor necrosis factor on amnion cell prostaglandin E2 production: implication for preterm labor |
| Q35217394 | Transforming growth factor-beta signaling in normal and malignant hematopoiesis |
| Q36531284 | Transforming growth factor-beta stimulates collagen VII expression by cutaneous cells in vitro |
| Q36778233 | Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms |
| Q38358575 | Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1 |
| Q40940716 | Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells |
| Q41198575 | Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies |
| Q44508741 | Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways |
| Q33973701 | Transforming growth factor-beta1 and prostate cancer |
| Q77793873 | Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts |
| Q46781499 | Transforming growth factor-beta1 regulates cell growth and causes downregulation of SMemb/non-muscle myosin heavy chain B mRNA in human prostate stromal cells |
| Q40751563 | Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects |
| Q24299131 | Transforming growth factor-beta1-induced hypertrophy and matrix expression in human bladder smooth muscle cells |
| Q41169453 | Transforming growth factor-beta2-mediated regulation of C3 gene expression in monocytes |
| Q73936225 | Transforming growth factor-beta: association with arteriosclerosis and left ventricular dysfunction after heart transplantation |
| Q40851998 | Transforming growth factor-beta: latent forms, binding proteins and receptors |
| Q77922697 | Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease |
| Q33893706 | Transforming growth factor-β (TGF-β) expression is increased in the subsynovial connective tissues of patients with idiopathic carpal tunnel syndrome. |
| Q52699075 | Transforming growth factor-β in liver cancer stem cells and regeneration. |
| Q71994945 | Transforming growth factor-β receptors on human endometrial cells: identification of the type I, II, and III receptors and glycosylphosphatidylinositol anchored TGF-β binding proteins |
| Q36550561 | Transforming growth factor-β-related genes in Drosophila and vertebrate development |
| Q28578335 | Transforming growth factor-β1 enhances the secretion of monocyte chemoattractant protein-1 by the IEC-18 intestinal epithelial cell line |
| Q35956465 | Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons |
| Q44591863 | Transforming growth factor‐beta isoform expression during bovine ovarian antral follicle development |
| Q41552504 | Transforming growth factor‐β1 stimulates macrophage urokinase expression and release of matrix‐bound basic fibroblast growth factor |
| Q57782930 | Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers |
| Q24625500 | Transient receptor potential (TRP) channels and cardiac fibrosis |
| Q40009553 | Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination |
| Q34236064 | Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway |
| Q37401564 | Triple combination of siRNAs targeting TGFβ1, TGFβR2, and CTGF enhances reduction of collagen I and smooth muscle actin in corneal fibroblasts. |
| Q46655391 | Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts |
| Q30699198 | Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells |
| Q40433328 | Tumor Heterogeneity and Immunotherapy of Cancer |
| Q37743207 | Tumor angiogenesis: insights and innovations |
| Q36573904 | Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein |
| Q41625163 | Tumor suppressor genes and human cancer |
| Q35787792 | Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients |
| Q36645287 | Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex |
| Q24612297 | Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin |
| Q36556324 | Tyrosine dephosphorylation of nuclear proteins mimics transforming growth factor beta 1 stimulation of alpha 2(I) collagen gene expression |
| Q73182923 | Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells |
| Q24317699 | Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium |
| Q44648515 | Tyrosine phosphorylation-dependent PI 3 kinase/Akt signal transduction regulates TGFbeta-induced fibronectin expression in mesangial cells |
| Q40913405 | Ubiquitin-dependent degradation of TGF-beta-activated smad2. |
| Q73233235 | Ultrastructural localisation of TGF-beta exposure in dentine by chemical treatment |
| Q40743036 | Upregulation by retinoic acid of transforming growth factor-beta-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases |
| Q40675691 | Upregulation of activin A gene by butyrate in human colon cancer cell lines |
| Q35393446 | Uric acid as a mediator of diabetic nephropathy |
| Q42828926 | Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. |
| Q47893515 | Use of myoblasts in assaying the osteoinductivity of bone morphogenetic proteins |
| Q40936571 | Use of representational difference analysis to study the effect of TGFB on the expression profile of a pancreatic cancer cell line |
| Q33932553 | Uterine epithelial cell proliferation and endometrial hyperplasia: evidence from a mouse model |
| Q35833446 | Vascular remodeling in primary pulmonary hypertension. Potential role for transforming growth factor-beta |
| Q48367393 | Vg1 orthology in the direct developing frog, Syrrhophus cystignathoides campi |
| Q46404967 | Visualisation of transforming growth factor-beta 1, tissue kallikrein, and kinin and transforming growth factor-beta receptors on human clear-cell renal carcinoma cells |
| Q92618965 | Vitamin D and pulmonary fibrosis: a review of molecular mechanisms |
| Q41580124 | Vitamin D3 and calcipotriol enhance the secretion of transforming growth factor-beta 1 and -beta 2 in cultured murine keratinocytes |
| Q74592752 | Wound repair |
| Q33207820 | Wound-healing studies in transgenic and knockout mice |
| Q38310184 | Yin Yang 1 (YY1) synergizes with Smad7 to inhibit TGF-β signaling in the nucleus. |
| Q73247690 | [Radiation-induced superficial fibrosis and TGF-alpha 1] |
| Q28262181 | gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development |
| Q24319021 | p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest |
| Q59310824 | p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells |
| Q28202242 | Transforming growth factor-beta (TGF-beta) binding to the extracellular domain of the type II TGF-beta receptor: receptor capture on a biosensor surface using a new coiled-coil capture system demonstrates that avidity contributes significantly to hi |
Search more.